Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106b-5p APC 1.47 0 -0.81 0 miRNAWalker2 validate; miRTarBase -0.16 0 23087084 miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells
2 hsa-miR-142-3p APC 3.98 0 -0.81 0 MirTarget; PITA; miRanda; miRNATAP -0.13 0 NA
3 hsa-miR-182-5p APC 3.22 0 -0.81 0 MirTarget -0.12 0 NA
4 hsa-miR-186-5p APC 0.85 0 -0.81 0 miRNAWalker2 validate -0.23 0 NA
5 hsa-miR-193a-3p APC 0.55 0.0319 -0.81 0 miRanda -0.12 1.0E-5 NA
6 hsa-miR-21-5p APC 4.38 0 -0.81 0 miRNAWalker2 validate -0.14 0 23773491; 24832083 The prognostic significance of APC gene mutation and miR 21 expression in advanced stage colorectal cancer; The aim of this study was to analyse the association of APC gene mutation and miR-21 expression with clinical outcome in CRC patients; APC gene mutation and expression of APC and miR-21 were analysed by direct DNA sequencing and real-time reverse transcription polymerase chain reaction; APC gene expression was low in CRC and negatively correlated with miR-21 expression and gene mutation; In Taiwan downregulation of the APC gene in CRC correlated with gene mutation and miR-21 upregulation; APC mutation and miR-21 expression could be used to predict the clinical outcome of CRC especially in patients with advanced disease;MicroRNA 21 promotes tumour malignancy via increased nuclear translocation of β catenin and predicts poor outcome in APC mutated but not in APC wild type colorectal cancer; However in our preliminary data the prognostic value of miR-21 levels was observed only in adenomatous polyposis coli APC-mutated tumours not in APC-wild-type tumours; We enrolled 165 colorectal tumour to determine APC mutation miR-21 levels and nuclear β-catenin expression by direct sequencing real-time PCR and immunohistochemistry
7 hsa-miR-210-3p APC 4.89 0 -0.81 0 miRNAWalker2 validate -0.11 0 NA
8 hsa-miR-450b-5p APC 1.69 0 -0.81 0 miRNATAP -0.13 0 NA
9 hsa-miR-589-3p APC 1.34 2.0E-5 -0.81 0 MirTarget -0.11 0 NA
10 hsa-miR-590-3p APC 0.84 0.00129 -0.81 0 PITA; miRanda; mirMAP; miRNATAP -0.21 0 NA
11 hsa-miR-7-1-3p APC 2.61 0 -0.81 0 MirTarget -0.11 9.0E-5 NA
12 hsa-let-7a-5p APC2 -1.37 0 1.14 0.00012 TargetScan -0.46 0 NA
13 hsa-miR-2110 APC2 -1.92 0 1.14 0.00012 MirTarget; miRNATAP -0.18 0.00032 NA
14 hsa-miR-221-5p APC2 -2.22 0 1.14 0.00012 mirMAP -0.1 0.00794 NA
15 hsa-miR-664a-5p APC2 -0.09 0.66227 1.14 0.00012 mirMAP -0.18 0.00537 NA
16 hsa-miR-335-5p AXIN1 -0.47 0.0677 0.53 3.0E-5 miRNAWalker2 validate -0.12 0 NA
17 hsa-miR-15a-5p AXIN2 1.63 0 -1.5 0 MirTarget; miRNATAP -0.22 0.00199 26252081 The combination of miR-15a and AXIN2 significantly improved the diagnostic accuracy
18 hsa-miR-221-3p AXIN2 -0.1 0.65445 -1.5 0 miRNATAP -0.19 0.00123 NA
19 hsa-miR-222-3p AXIN2 0.03 0.88194 -1.5 0 miRNATAP -0.25 3.0E-5 NA
20 hsa-miR-424-5p AXIN2 1.26 1.0E-5 -1.5 0 MirTarget; miRNATAP -0.2 2.0E-5 NA
21 hsa-miR-590-3p AXIN2 0.84 0.00129 -1.5 0 MirTarget; PITA; miRanda; miRNATAP -0.26 1.0E-5 NA
22 hsa-miR-103a-3p BTRC 0.54 2.0E-5 0.05 0.62283 MirTarget; miRNATAP -0.11 0.00156 NA
23 hsa-miR-16-5p BTRC 0.75 0 0.05 0.62283 miRNAWalker2 validate; MirTarget; miRNATAP -0.11 8.0E-5 NA
24 hsa-miR-342-3p BTRC -0.13 0.56103 0.05 0.62283 mirMAP -0.14 0 NA
25 hsa-miR-195-3p CACYBP -1.33 0 0.79 0 mirMAP -0.22 0 NA
26 hsa-miR-30a-3p CACYBP -2.54 0 0.79 0 MirTarget -0.16 0 NA
27 hsa-miR-320a CACYBP -0.96 0 0.79 0 miRanda -0.22 0 NA
28 hsa-miR-130b-5p CAMK2A 1.54 0 -1.98 0 mirMAP -0.25 0 NA
29 hsa-miR-148b-5p CAMK2A 1.39 0 -1.98 0 mirMAP -0.28 1.0E-5 NA
30 hsa-miR-15b-3p CAMK2A 0.8 0.0004 -1.98 0 mirMAP -0.33 0 NA
31 hsa-miR-19b-1-5p CAMK2A 1.71 0 -1.98 0 mirMAP -0.34 0 NA
32 hsa-miR-21-3p CAMK2A 2.54 0 -1.98 0 MirTarget -0.32 0 NA
33 hsa-miR-25-3p CAMK2A 0.36 0.01637 -1.98 0 MirTarget -0.43 1.0E-5 NA
34 hsa-miR-429 CAMK2A 2.38 0 -1.98 0 miRNATAP -0.2 3.0E-5 NA
35 hsa-miR-582-3p CAMK2A 1.71 0 -1.98 0 mirMAP -0.13 0.00211 NA
36 hsa-miR-625-5p CAMK2A 1.38 0 -1.98 0 mirMAP -0.18 0.00215 NA
37 hsa-miR-7-1-3p CAMK2A 2.61 0 -1.98 0 MirTarget -0.32 0 NA
38 hsa-miR-92a-3p CAMK2A -0.14 0.49341 -1.98 0 MirTarget -0.26 0.00053 NA
39 hsa-miR-92b-3p CAMK2A 0.05 0.83172 -1.98 0 MirTarget -0.21 0.0012 NA
40 hsa-miR-29a-3p CAMK2B 0.1 0.5732 1.37 0.0148 mirMAP -0.57 8.0E-5 NA
41 hsa-miR-185-5p CAMK2D 1.14 0 -0.09 0.59253 miRNATAP -0.15 0.00303 NA
42 hsa-miR-197-3p CAMK2D -1.3 0 -0.09 0.59253 miRNATAP -0.12 9.0E-5 NA
43 hsa-miR-27a-3p CAMK2D 0.43 0.00737 -0.09 0.59253 miRNATAP -0.19 9.0E-5 NA
44 hsa-miR-320b CAMK2D 0.23 0.37882 -0.09 0.59253 miRanda -0.11 0.00021 NA
45 hsa-miR-342-3p CAMK2D -0.13 0.56103 -0.09 0.59253 miRanda -0.17 0 NA
46 hsa-miR-484 CAMK2D -0.23 0.24411 -0.09 0.59253 miRNAWalker2 validate -0.13 0.00108 NA
47 hsa-miR-582-5p CAMK2D 1.08 0.00149 -0.09 0.59253 mirMAP -0.16 0 NA
48 hsa-miR-590-3p CAMK2D 0.84 0.00129 -0.09 0.59253 miRanda; mirMAP -0.13 0.00039 NA
49 hsa-miR-708-3p CAMK2D 3.44 0 -0.09 0.59253 mirMAP -0.11 4.0E-5 NA
50 hsa-miR-193a-5p CAMK2G -1.16 0 0.08 0.5178 miRNATAP -0.11 5.0E-5 NA
51 hsa-miR-106a-5p CCND1 1.39 6.0E-5 -0.3 0.2554 MirTarget; miRNATAP -0.25 0 NA
52 hsa-miR-106b-5p CCND1 1.47 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.26 1.0E-5 NA
53 hsa-miR-142-3p CCND1 3.98 0 -0.3 0.2554 miRanda -0.12 0.00053 23619912 Transfection of miR-142-3p mimics in colon cancer cells downregulated cyclin D1 expression induced G1 phase cell cycle arrest and elevated the sensitivity of the cells to 5-fluorouracil
54 hsa-miR-15a-5p CCND1 1.63 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.2 0.00193 22922827 CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR
55 hsa-miR-15b-5p CCND1 -1.26 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.3 0 NA
56 hsa-miR-16-1-3p CCND1 1.5 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase -0.25 3.0E-5 22922827; 18483394 CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL
57 hsa-miR-16-5p CCND1 0.75 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.37 0 23991964; 22922827; 18483394 At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL
58 hsa-miR-17-5p CCND1 2.07 0 -0.3 0.2554 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.31 0 26431674 Bioinformatics Prediction and In Vitro Analysis Revealed That miR 17 Targets Cyclin D1 mRNA in Triple Negative Breast Cancer Cells; In this study using bioinformatic analyses miR-17 was selected as it targets the 3'UTR of CCND1 gene with the highest score; After lentiviral transduction of miR-17 to the target cells gene expression analysis showed decreased expression of CCND1 gene
59 hsa-miR-186-5p CCND1 0.85 0 -0.3 0.2554 mirMAP -0.38 1.0E-5 NA
60 hsa-miR-193a-3p CCND1 0.55 0.0319 -0.3 0.2554 MirTarget; PITA; miRanda -0.19 0.00016 NA
61 hsa-miR-193b-3p CCND1 1.1 0.00082 -0.3 0.2554 miRNAWalker2 validate; miRTarBase; MirTarget -0.15 4.0E-5 27071318; 20655737; 20304954; 21893020; 26129688 MicroRNA 193b inhibits the proliferation migration and invasion of gastric cancer cells via targeting cyclin D1; Further mechanism study indicated that CCND1 was a direct target of miR-193b in GC;CCND1 and ETS1 were revealed to be regulated by miR-193b directly;MicroRNA 193b represses cell proliferation and regulates cyclin D1 in melanoma; Overexpression of miR-193b in Malme-3M cells down-regulated CCND1 mRNA and protein by > or = 50%; A luciferase reporter assay confirmed that miR-193b directly regulates CCND1 by binding to the 3'untranslated region of CCND1 mRNA; These studies indicate that miR-193b represses cell proliferation and regulates CCND1 expression and suggest that dysregulation of miR-193b may play an important role in melanoma development;In a previous study we reported that miR-193b represses cell proliferation and regulates cyclin D1 in melanoma cells suggesting that miR-193b could act as a tumor suppressor;Epigenetically altered miR 193b targets cyclin D1 in prostate cancer; It has been suggested that miR-193b targets cyclin D1 in several malignancies; Here our aim was to determine if miR-193b targets cyclin D1 in prostate cancer; Furthermore the PC cell lines 22Rv1 and VCaP which express low levels of miR-193b and high levels of CCND1 showed significant growth retardation when treated with a CDK4/6 inhibitor; In contrast the inhibitor had no effect on the growth of PC-3 and DU145 cells with high miR-193b and low CCND1 expression; Taken together our data demonstrate that miR-193b targets cyclin D1 in prostate cancer
62 hsa-miR-19a-3p CCND1 2.12 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase; miRNATAP -0.22 0 25985117 Moreover miR-19a might play inhibitory roles in HCC malignancy via regulating Cyclin D1 expression
63 hsa-miR-19b-1-5p CCND1 1.71 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase -0.3 0 NA
64 hsa-miR-19b-3p CCND1 2.11 0 -0.3 0.2554 miRNATAP -0.18 0.0002 NA
65 hsa-miR-20a-5p CCND1 2.65 0 -0.3 0.2554 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.24 0 NA
66 hsa-miR-20b-5p CCND1 1.36 0.00261 -0.3 0.2554 MirTarget; miRNATAP -0.18 0 NA
67 hsa-miR-365a-3p CCND1 0.01 0.9536 -0.3 0.2554 miRNAWalker2 validate; miRTarBase -0.19 0.00023 NA
68 hsa-miR-374a-5p CCND1 -0.2 0.29808 -0.3 0.2554 MirTarget -0.31 1.0E-5 27191497 microRNA 374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway; Furthermore luciferase reporter assays confirmed that miR-374a could directly reduce CCND1; We examined miR-374a levels by in situ hybridization and its correlation with CCND1 expression in CRC tumor tissues; High miR-374a expression with low level of CCND1 was protective factor in CRC; Together these findings indicate that miR-374a inactivates the PI3K/AKT axis by inhibiting CCND1 suppressing of colon cancer progression
69 hsa-miR-374b-5p CCND1 0.47 0.01092 -0.3 0.2554 miRNAWalker2 validate; MirTarget -0.26 0.00012 NA
70 hsa-miR-425-5p CCND1 1.22 0 -0.3 0.2554 miRNAWalker2 validate -0.25 1.0E-5 NA
71 hsa-miR-589-3p CCND1 1.34 2.0E-5 -0.3 0.2554 MirTarget -0.13 0.00079 NA
72 hsa-miR-590-3p CCND1 0.84 0.00129 -0.3 0.2554 mirMAP -0.18 0.00086 NA
73 hsa-miR-769-3p CCND1 0.45 0.07482 -0.3 0.2554 mirMAP -0.14 0.00277 NA
74 hsa-miR-92a-3p CCND1 -0.14 0.49341 -0.3 0.2554 miRNAWalker2 validate -0.34 0 NA
75 hsa-miR-93-5p CCND1 1.51 0 -0.3 0.2554 miRNAWalker2 validate; MirTarget; miRNATAP -0.32 0 NA
76 hsa-miR-942-5p CCND1 -0.04 0.87063 -0.3 0.2554 MirTarget -0.18 0.00098 NA
77 hsa-miR-106a-5p CCND2 1.39 6.0E-5 -1.64 0 miRNATAP -0.15 2.0E-5 NA
78 hsa-miR-106b-5p CCND2 1.47 0 -1.64 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.38 0 NA
79 hsa-miR-130b-5p CCND2 1.54 0 -1.64 0 mirMAP -0.27 0 NA
80 hsa-miR-141-3p CCND2 3.37 0 -1.64 0 MirTarget; TargetScan -0.24 0 NA
81 hsa-miR-151a-3p CCND2 0.67 0.00028 -1.64 0 mirMAP -0.28 0 NA
82 hsa-miR-15a-5p CCND2 1.63 0 -1.64 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.16 0.00712 NA
83 hsa-miR-17-5p CCND2 2.07 0 -1.64 0 miRNAWalker2 validate; miRTarBase; TargetScan; miRNATAP -0.37 0 NA
84 hsa-miR-182-5p CCND2 3.22 0 -1.64 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.37 0 NA
85 hsa-miR-183-5p CCND2 2.39 0 -1.64 0 miRNATAP -0.41 0 NA
86 hsa-miR-185-5p CCND2 1.14 0 -1.64 0 MirTarget; miRNATAP -0.24 0.00048 NA
87 hsa-miR-186-5p CCND2 0.85 0 -1.64 0 mirMAP; miRNATAP -0.36 1.0E-5 NA
88 hsa-miR-191-5p CCND2 0.34 0.06681 -1.64 0 MirTarget -0.2 0.00075 NA
89 hsa-miR-19a-3p CCND2 2.12 0 -1.64 0 MirTarget; miRNATAP -0.17 1.0E-5 NA
90 hsa-miR-19b-3p CCND2 2.11 0 -1.64 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.19 1.0E-5 NA
91 hsa-miR-200a-3p CCND2 3.15 0 -1.64 0 MirTarget -0.17 0 NA
92 hsa-miR-20a-5p CCND2 2.65 0 -1.64 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.28 0 NA
93 hsa-miR-21-3p CCND2 2.54 0 -1.64 0 mirMAP -0.21 0 NA
94 hsa-miR-2355-3p CCND2 1.11 1.0E-5 -1.64 0 miRNATAP -0.22 0 NA
95 hsa-miR-28-5p CCND2 1.2 0 -1.64 0 miRanda -0.29 0.00018 NA
96 hsa-miR-301a-3p CCND2 2.7 0 -1.64 0 miRNAWalker2 validate -0.27 0 NA
97 hsa-miR-320b CCND2 0.23 0.37882 -1.64 0 mirMAP; miRNATAP -0.12 0.00373 NA
98 hsa-miR-324-3p CCND2 -0.08 0.68923 -1.64 0 miRNAWalker2 validate -0.28 0 NA
99 hsa-miR-331-5p CCND2 0.58 0.00131 -1.64 0 miRNATAP -0.28 1.0E-5 NA
100 hsa-miR-429 CCND2 2.38 0 -1.64 0 miRNATAP -0.21 0 NA
101 hsa-miR-450b-5p CCND2 1.69 0 -1.64 0 MirTarget; PITA; miRNATAP -0.15 9.0E-5 NA
102 hsa-miR-501-5p CCND2 0.41 0.10435 -1.64 0 PITA; mirMAP; miRNATAP -0.14 0.00086 NA
103 hsa-miR-503-5p CCND2 1.97 0 -1.64 0 MirTarget -0.13 5.0E-5 25860935 We then identified two targets of miR-503 CCND2 and CCND3
104 hsa-miR-550a-5p CCND2 0.6 0.03148 -1.64 0 MirTarget -0.22 0 NA
105 hsa-miR-589-3p CCND2 1.34 2.0E-5 -1.64 0 mirMAP -0.19 0 NA
106 hsa-miR-590-3p CCND2 0.84 0.00129 -1.64 0 miRanda; mirMAP -0.13 0.00821 NA
107 hsa-miR-590-5p CCND2 2.07 0 -1.64 0 mirMAP -0.26 0 NA
108 hsa-miR-660-5p CCND2 2.05 0 -1.64 0 mirMAP -0.15 0.00131 NA
109 hsa-miR-7-1-3p CCND2 2.61 0 -1.64 0 mirMAP -0.26 0 NA
110 hsa-miR-877-5p CCND2 -0.37 0.20671 -1.64 0 miRNAWalker2 validate -0.15 6.0E-5 NA
111 hsa-miR-93-5p CCND2 1.51 0 -1.64 0 miRNATAP -0.41 0 NA
112 hsa-miR-96-5p CCND2 3.04 0 -1.64 0 TargetScan; miRNATAP -0.36 0 NA
113 hsa-miR-320b CCND3 0.23 0.37882 -0.86 1.0E-5 miRanda -0.11 0.00235 NA
114 hsa-miR-421 CCND3 0.17 0.53528 -0.86 1.0E-5 PITA; miRanda -0.12 0.00073 NA
115 hsa-miR-96-5p CCND3 3.04 0 -0.86 1.0E-5 TargetScan -0.12 0.00015 NA
116 hsa-miR-140-5p CHD8 0.67 0.00034 0.13 0.25233 miRanda -0.12 3.0E-5 NA
117 hsa-miR-26b-5p CREBBP 0.72 5.0E-5 -0.12 0.3327 miRNATAP -0.11 0.00062 NA
118 hsa-miR-590-3p CREBBP 0.84 0.00129 -0.12 0.3327 PITA; miRanda; mirMAP; miRNATAP -0.14 0 NA
119 hsa-miR-186-5p CSNK1A1 0.85 0 0.1 0.35405 miRNAWalker2 validate; miRNATAP -0.1 0.00263 NA
120 hsa-miR-576-5p CSNK1A1 1.03 0 0.1 0.35405 mirMAP -0.12 0 NA
121 hsa-miR-30a-3p CSNK1E -2.54 0 0.28 0.03634 miRNATAP -0.1 0 NA
122 hsa-miR-125a-5p CSNK2A1 -1.05 0 0.42 0.00051 MirTarget; PITA; miRanda -0.14 0 NA
123 hsa-miR-146b-5p CSNK2A1 1.09 1.0E-5 0.42 0.00051 miRanda -0.15 0 NA
124 hsa-miR-362-3p CSNK2A1 0.19 0.52808 0.42 0.00051 miRanda; miRNATAP -0.1 1.0E-5 NA
125 hsa-miR-186-5p CSNK2A2 0.85 0 -0.19 0.06425 mirMAP -0.14 3.0E-5 NA
126 hsa-miR-342-3p CTBP2 -0.13 0.56103 0.4 0.00034 MirTarget; PITA; miRanda; miRNATAP -0.16 0 NA
127 hsa-miR-532-3p CTNNB1 -0.68 0.01476 -0.01 0.94149 miRNAWalker2 validate -0.11 1.0E-5 NA
128 hsa-miR-421 CTNNBIP1 0.17 0.53528 -0.64 5.0E-5 miRanda; mirMAP -0.14 0 NA
129 hsa-miR-130a-3p CXXC4 0.88 0.00016 0.06 0.89857 miRNATAP -0.25 0.00476 NA
130 hsa-miR-146a-5p CXXC4 0.68 0.01053 0.06 0.89857 MirTarget -0.35 1.0E-5 NA
131 hsa-miR-146b-5p CXXC4 1.09 1.0E-5 0.06 0.89857 MirTarget; miRNATAP -0.46 0 NA
132 hsa-miR-21-5p CXXC4 4.38 0 0.06 0.89857 mirMAP -0.22 0.00421 NA
133 hsa-miR-224-3p CXXC4 0.92 0.01001 0.06 0.89857 mirMAP -0.17 0.00362 NA
134 hsa-miR-224-5p CXXC4 1.92 0 0.06 0.89857 MirTarget -0.2 6.0E-5 NA
135 hsa-miR-450b-5p CXXC4 1.69 0 0.06 0.89857 MirTarget; miRNATAP -0.23 0.00089 NA
136 hsa-miR-452-5p CXXC4 0.64 0.04582 0.06 0.89857 miRNATAP -0.17 0.00786 NA
137 hsa-miR-186-5p DAAM1 0.85 0 -0.44 0.00894 MirTarget; mirMAP -0.18 0.00156 NA
138 hsa-miR-19a-3p DAAM1 2.12 0 -0.44 0.00894 miRNATAP -0.14 0 NA
139 hsa-miR-19b-3p DAAM1 2.11 0 -0.44 0.00894 miRNATAP -0.14 1.0E-5 NA
140 hsa-miR-21-5p DAAM1 4.38 0 -0.44 0.00894 miRNAWalker2 validate -0.13 1.0E-5 NA
141 hsa-miR-29a-3p DAAM1 0.1 0.5732 -0.44 0.00894 MirTarget; miRNATAP -0.15 0.00066 NA
142 hsa-miR-29b-3p DAAM1 3.11 0 -0.44 0.00894 MirTarget; miRNATAP -0.2 0 NA
143 hsa-miR-32-5p DAAM1 0.88 6.0E-5 -0.44 0.00894 miRNATAP -0.13 0.00063 NA
144 hsa-miR-34a-5p DAAM1 1.41 0 -0.44 0.00894 MirTarget; miRNATAP -0.17 1.0E-5 NA
145 hsa-miR-454-3p DAAM1 1.49 0 -0.44 0.00894 MirTarget; miRNATAP -0.17 0 NA
146 hsa-miR-576-5p DAAM1 1.03 0 -0.44 0.00894 mirMAP -0.14 0.00011 NA
147 hsa-miR-590-3p DAAM1 0.84 0.00129 -0.44 0.00894 MirTarget; miRanda; mirMAP -0.11 0.00166 NA
148 hsa-miR-141-5p DAAM2 3.03 0 -1.64 0 mirMAP -0.2 0.00064 NA
149 hsa-miR-182-5p DAAM2 3.22 0 -1.64 0 mirMAP -0.21 0.00026 NA
150 hsa-miR-18a-5p DAAM2 1.37 1.0E-5 -1.64 0 miRNAWalker2 validate -0.28 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALING PATHWAY 73 351 1.086e-102 5.054e-99
2 CANONICAL WNT SIGNALING PATHWAY 38 95 5.908e-63 1.374e-59
3 REGULATION OF WNT SIGNALING PATHWAY 46 310 2.965e-54 4.599e-51
4 NON CANONICAL WNT SIGNALING PATHWAY 35 140 2.286e-49 2.659e-46
5 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 32 197 1.745e-38 1.624e-35
6 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 33 236 1.91e-37 1.481e-34
7 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 51 1021 2.786e-36 1.852e-33
8 POSITIVE REGULATION OF RESPONSE TO STIMULUS 62 1929 3.493e-34 2.032e-31
9 POSITIVE REGULATION OF GENE EXPRESSION 58 1733 1.849e-32 9.559e-30
10 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 57 1672 3.238e-32 1.507e-29
11 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 54 1492 1.563e-31 6.613e-29
12 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 18 39 3.329e-31 1.291e-28
13 REGULATION OF ORGAN MORPHOGENESIS 28 242 2.577e-29 9.225e-27
14 POSITIVE REGULATION OF CELL COMMUNICATION 52 1532 7.734e-29 2.57e-26
15 MORPHOGENESIS OF AN EPITHELIUM 32 400 2.215e-28 6.872e-26
16 TISSUE MORPHOGENESIS 35 533 3.648e-28 1.061e-25
17 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 24 162 8.11e-28 2.22e-25
18 EPITHELIUM DEVELOPMENT 42 945 2.83e-27 7.314e-25
19 TISSUE DEVELOPMENT 50 1518 5.72e-27 1.401e-24
20 REGULATION OF PROTEIN MODIFICATION PROCESS 52 1710 1.471e-26 3.423e-24
21 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 53 1805 2.024e-26 4.368e-24
22 NEGATIVE REGULATION OF CELL COMMUNICATION 45 1192 2.065e-26 4.368e-24
23 ORGAN MORPHOGENESIS 39 841 7.136e-26 1.444e-23
24 REGULATION OF CELL DIFFERENTIATION 48 1492 2.668e-25 5.173e-23
25 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 20 110 3.728e-25 6.938e-23
26 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 46 1360 4.913e-25 8.792e-23
27 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 13 22 1.094e-24 1.886e-22
28 TUBE MORPHOGENESIS 27 323 2.023e-24 3.362e-22
29 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 42 1135 3.704e-24 5.943e-22
30 TUBE DEVELOPMENT 32 552 5.225e-24 8.104e-22
31 REGULATION OF PHOSPHORUS METABOLIC PROCESS 48 1618 9.116e-24 1.368e-21
32 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 31 554 8.677e-23 1.262e-20
33 EMBRYO DEVELOPMENT 37 894 9.177e-23 1.294e-20
34 PATTERN SPECIFICATION PROCESS 28 418 1.122e-22 1.535e-20
35 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 39 1036 1.406e-22 1.818e-20
36 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 39 1036 1.406e-22 1.818e-20
37 CARDIOVASCULAR SYSTEM DEVELOPMENT 35 788 1.759e-22 2.153e-20
38 CIRCULATORY SYSTEM DEVELOPMENT 35 788 1.759e-22 2.153e-20
39 NEURON DIFFERENTIATION 36 874 4.739e-22 5.654e-20
40 EMBRYONIC MORPHOGENESIS 30 539 5.613e-22 6.529e-20
41 POSITIVE REGULATION OF MOLECULAR FUNCTION 48 1791 7.153e-22 8.118e-20
42 CELL FATE COMMITMENT 22 227 2.261e-21 2.505e-19
43 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 39 1142 4.541e-21 4.913e-19
44 REGIONALIZATION 24 311 6.552e-21 6.929e-19
45 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 36 957 9.649e-21 9.977e-19
46 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 19 152 1.102e-20 1.114e-18
47 NEUROGENESIS 42 1402 1.176e-20 1.164e-18
48 INTRACELLULAR SIGNAL TRANSDUCTION 44 1572 1.413e-20 1.37e-18
49 REGULATION OF CELLULAR PROTEIN LOCALIZATION 29 552 1.51e-20 1.434e-18
50 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 38 1152 5.594e-20 5.206e-18
51 REGULATION OF EMBRYONIC DEVELOPMENT 17 114 6.007e-20 5.481e-18
52 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 41 1395 8.042e-20 7.196e-18
53 POSITIVE REGULATION OF CELL DIFFERENTIATION 33 823 8.506e-20 7.468e-18
54 SENSORY ORGAN DEVELOPMENT 27 493 1.349e-19 1.162e-17
55 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 24 365 2.789e-19 2.337e-17
56 REGULATION OF BINDING 22 283 2.812e-19 2.337e-17
57 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 23 337 7.389e-19 6.032e-17
58 DORSAL VENTRAL AXIS SPECIFICATION 10 20 3.23e-18 2.591e-16
59 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 34 1004 3.871e-18 3.053e-16
60 HEART DEVELOPMENT 25 466 5.959e-18 4.621e-16
61 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 43 1784 1.268e-17 9.673e-16
62 ANTERIOR POSTERIOR PATTERN SPECIFICATION 18 194 2.817e-17 2.114e-15
63 REGULATION OF CELL DEATH 39 1472 3.052e-17 2.254e-15
64 CELL PROLIFERATION 28 672 3.339e-17 2.427e-15
65 EMBRYONIC ORGAN DEVELOPMENT 23 406 4.554e-17 3.26e-15
66 REGULATION OF PROTEIN LOCALIZATION 32 950 5.563e-17 3.922e-15
67 REGULATION OF CELLULAR RESPONSE TO STRESS 28 691 6.845e-17 4.754e-15
68 CELL DEVELOPMENT 38 1426 7.418e-17 5.076e-15
69 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 15 119 1.411e-16 9.513e-15
70 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 40 1656 2.514e-16 1.671e-14
71 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 42 1848 2.926e-16 1.917e-14
72 REGULATION OF CELL MORPHOGENESIS 25 552 3.169e-16 2.048e-14
73 GASTRULATION 16 155 3.339e-16 2.12e-14
74 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 29 801 3.372e-16 2.12e-14
75 PROTEIN PHOSPHORYLATION 31 944 3.878e-16 2.406e-14
76 REGULATION OF CELL CYCLE 31 949 4.488e-16 2.748e-14
77 POSITIVE REGULATION OF CATALYTIC ACTIVITY 38 1518 5.788e-16 3.498e-14
78 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 16 162 6.799e-16 4.056e-14
79 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 15 134 8.706e-16 5.128e-14
80 EMBRYONIC ORGAN MORPHOGENESIS 19 279 1.115e-15 6.487e-14
81 SENSORY ORGAN MORPHOGENESIS 18 239 1.153e-15 6.542e-14
82 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 20 323 1.15e-15 6.542e-14
83 FC EPSILON RECEPTOR SIGNALING PATHWAY 15 142 2.101e-15 1.178e-13
84 SEGMENTATION 13 89 2.277e-15 1.261e-13
85 AXIS SPECIFICATION 13 90 2.65e-15 1.434e-13
86 POSITIVE REGULATION OF CELL DEATH 25 605 2.63e-15 1.434e-13
87 DORSAL VENTRAL PATTERN FORMATION 13 91 3.077e-15 1.646e-13
88 REGULATION OF TRANSFERASE ACTIVITY 30 946 3.28e-15 1.734e-13
89 REGULATION OF PROTEIN CATABOLIC PROCESS 21 393 3.924e-15 2.051e-13
90 NEURAL TUBE DEVELOPMENT 15 149 4.348e-15 2.248e-13
91 REGULATION OF CELLULAR LOCALIZATION 34 1277 5.296e-15 2.708e-13
92 CELL ACTIVATION 24 568 6.314e-15 3.193e-13
93 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 23 513 7.134e-15 3.569e-13
94 REGULATION OF RESPONSE TO STRESS 36 1468 8.252e-15 4.085e-13
95 REGULATION OF CELL DEVELOPMENT 28 836 8.562e-15 4.193e-13
96 REGULATION OF KINASE ACTIVITY 27 776 1.129e-14 5.473e-13
97 REGULATION OF JNK CASCADE 15 159 1.154e-14 5.538e-13
98 SOMITE DEVELOPMENT 12 78 1.485e-14 6.979e-13
99 REGULATION OF CELL PROLIFERATION 36 1496 1.472e-14 6.979e-13
100 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 16 197 1.527e-14 7.105e-13
101 DOPAMINERGIC NEURON DIFFERENTIATION 9 28 2.271e-14 1.046e-12
102 SOMITOGENESIS 11 62 3.718e-14 1.696e-12
103 CELLULAR RESPONSE TO RETINOIC ACID 11 65 6.458e-14 2.918e-12
104 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 16 220 8.614e-14 3.854e-12
105 REGULATION OF PROTEIN TARGETING 18 307 8.95e-14 3.966e-12
106 REGULATION OF PROTEIN IMPORT 15 183 9.35e-14 4.104e-12
107 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 35 1517 1.336e-13 5.809e-12
108 POSITIVE REGULATION OF CELL DEVELOPMENT 21 472 1.426e-13 6.145e-12
109 NEURAL TUBE FORMATION 12 94 1.517e-13 6.476e-12
110 STEM CELL DIFFERENTIATION 15 190 1.626e-13 6.88e-12
111 REGULATION OF MAPK CASCADE 24 660 1.674e-13 7.016e-12
112 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 19 381 3.135e-13 1.302e-11
113 TUBE FORMATION 13 129 3.176e-13 1.308e-11
114 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 23 616 3.345e-13 1.365e-11
115 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 7 14 4.45e-13 1.785e-11
116 CONVERGENT EXTENSION 7 14 4.45e-13 1.785e-11
117 PHOSPHORYLATION 31 1228 4.754e-13 1.891e-11
118 NEGATIVE REGULATION OF GENE EXPRESSION 34 1493 4.838e-13 1.908e-11
119 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 39 1977 5.004e-13 1.957e-11
120 REGULATION OF PROTEIN BINDING 14 168 5.23e-13 2.028e-11
121 EPITHELIAL TO MESENCHYMAL TRANSITION 10 56 5.274e-13 2.028e-11
122 FC RECEPTOR SIGNALING PATHWAY 15 206 5.322e-13 2.03e-11
123 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 13 135 5.742e-13 2.172e-11
124 HEAD DEVELOPMENT 24 709 7.787e-13 2.922e-11
125 HEART MORPHOGENESIS 15 212 8.087e-13 3.01e-11
126 REGULATION OF PROTEOLYSIS 24 711 8.27e-13 3.054e-11
127 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 15 218 1.213e-12 4.446e-11
128 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 20 470 1.318e-12 4.79e-11
129 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 16 263 1.355e-12 4.887e-11
130 REGULATION OF STEM CELL DIFFERENTIATION 12 113 1.439e-12 5.15e-11
131 REGULATION OF CATABOLIC PROCESS 24 731 1.492e-12 5.301e-11
132 RESPONSE TO GROWTH FACTOR 20 475 1.6e-12 5.639e-11
133 RESPONSE TO OXYGEN CONTAINING COMPOUND 32 1381 1.815e-12 6.349e-11
134 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 24 740 1.935e-12 6.718e-11
135 REGULATION OF CYTOPLASMIC TRANSPORT 20 481 2.013e-12 6.937e-11
136 POSITIVE REGULATION OF KINASE ACTIVITY 20 482 2.091e-12 7.153e-11
137 NEGATIVE REGULATION OF CELL DIFFERENTIATION 22 609 2.258e-12 7.668e-11
138 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 15 228 2.323e-12 7.832e-11
139 REGULATION OF IMMUNE SYSTEM PROCESS 32 1403 2.766e-12 9.26e-11
140 MESENCHYME DEVELOPMENT 14 190 2.831e-12 9.407e-11
141 REGULATION OF INTRACELLULAR TRANSPORT 22 621 3.316e-12 1.094e-10
142 REGULATION OF TRANSPORT 36 1804 3.963e-12 1.298e-10
143 DEVELOPMENTAL GROWTH 17 333 4.277e-12 1.392e-10
144 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 16 289 5.682e-12 1.836e-10
145 CELLULAR RESPONSE TO LIPID 19 457 7.651e-12 2.455e-10
146 RHYTHMIC PROCESS 16 298 9.027e-12 2.877e-10
147 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 24 799 9.721e-12 3.077e-10
148 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 25 876 1.009e-11 3.171e-10
149 VASCULATURE DEVELOPMENT 19 469 1.199e-11 3.743e-10
150 POSITIVE REGULATION OF MAPK CASCADE 19 470 1.243e-11 3.857e-10
151 RESPONSE TO LIPID 25 888 1.352e-11 4.167e-10
152 RESPONSE TO RETINOIC ACID 11 107 1.843e-11 5.641e-10
153 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 23 750 1.863e-11 5.666e-10
154 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 26 983 1.954e-11 5.902e-10
155 REGULATION OF HYDROLASE ACTIVITY 30 1327 1.995e-11 5.988e-10
156 REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 13 181 2.458e-11 7.331e-10
157 REGULATION OF JUN KINASE ACTIVITY 10 81 2.48e-11 7.349e-10
158 MACROMOLECULAR COMPLEX DISASSEMBLY 13 182 2.635e-11 7.662e-10
159 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 12 144 2.617e-11 7.662e-10
160 NEGATIVE REGULATION OF MOLECULAR FUNCTION 27 1079 2.621e-11 7.662e-10
161 CELL CYCLE PROCESS 27 1081 2.734e-11 7.901e-10
162 EMBRYONIC PATTERN SPECIFICATION 9 58 3.049e-11 8.758e-10
163 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 15 274 3.217e-11 9.183e-10
164 EYE DEVELOPMENT 16 326 3.468e-11 9.78e-10
165 REGULATION OF ORGANELLE ORGANIZATION 28 1178 3.449e-11 9.78e-10
166 REGULATION OF IMMUNE RESPONSE 24 858 4.264e-11 1.195e-09
167 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 11 117 4.928e-11 1.373e-09
168 NEGATIVE REGULATION OF CELL DEATH 24 872 5.95e-11 1.638e-09
169 CENTRAL NERVOUS SYSTEM DEVELOPMENT 24 872 5.95e-11 1.638e-09
170 GLAND DEVELOPMENT 17 395 6.299e-11 1.724e-09
171 POSITIVE REGULATION OF JUN KINASE ACTIVITY 9 63 6.623e-11 1.802e-09
172 MIDBRAIN DEVELOPMENT 10 90 7.245e-11 1.96e-09
173 BETA CATENIN TCF COMPLEX ASSEMBLY 8 43 8.6e-11 2.313e-09
174 CELL CYCLE 29 1316 8.667e-11 2.318e-09
175 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 17 406 9.653e-11 2.567e-09
176 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 1.085e-10 2.869e-09
177 GROWTH 17 410 1.124e-10 2.954e-09
178 CELLULAR COMPONENT MORPHOGENESIS 24 900 1.136e-10 2.97e-09
179 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 67 1.175e-10 3.053e-09
180 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 16 360 1.507e-10 3.896e-09
181 NEGATIVE REGULATION OF BINDING 11 131 1.69e-10 4.344e-09
182 POSITIVE REGULATION OF PROTEOLYSIS 16 363 1.703e-10 4.353e-09
183 PARAXIAL MESODERM DEVELOPMENT 6 16 1.951e-10 4.962e-09
184 MESENCHYMAL CELL DIFFERENTIATION 11 134 2.159e-10 5.46e-09
185 DIGESTIVE TRACT MORPHOGENESIS 8 48 2.187e-10 5.501e-09
186 REGULATION OF CELL CYCLE PROCESS 19 558 2.322e-10 5.809e-09
187 MUSCLE STRUCTURE DEVELOPMENT 17 432 2.518e-10 6.265e-09
188 CELLULAR RESPONSE TO ACID CHEMICAL 12 175 2.565e-10 6.348e-09
189 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 8 50 3.083e-10 7.591e-09
190 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 19 573 3.624e-10 8.875e-09
191 INOSITOL PHOSPHATE MEDIATED SIGNALING 6 18 4.483e-10 1.092e-08
192 EMBRYONIC AXIS SPECIFICATION 7 33 5.08e-10 1.231e-08
193 NEGATIVE REGULATION OF PROTEIN BINDING 9 79 5.35e-10 1.29e-08
194 FORMATION OF PRIMARY GERM LAYER 10 110 5.417e-10 1.299e-08
195 SKELETAL SYSTEM DEVELOPMENT 17 455 5.572e-10 1.329e-08
196 POSITIVE REGULATION OF CATABOLIC PROCESS 16 395 5.85e-10 1.389e-08
197 REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 11 148 6.292e-10 1.479e-08
198 PEPTIDYL SERINE MODIFICATION 11 148 6.292e-10 1.479e-08
199 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 7 34 6.367e-10 1.481e-08
200 SINGLE ORGANISM CELL ADHESION 17 459 6.367e-10 1.481e-08
201 RESPONSE TO ENDOGENOUS STIMULUS 29 1450 8.433e-10 1.952e-08
202 REGULATION OF MITOTIC CELL CYCLE 17 468 8.554e-10 1.97e-08
203 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 11 154 9.621e-10 2.205e-08
204 CELL DEATH 24 1001 9.703e-10 2.213e-08
205 RESPIRATORY SYSTEM DEVELOPMENT 12 197 1.003e-09 2.277e-08
206 PALATE DEVELOPMENT 9 85 1.041e-09 2.352e-08
207 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 20 684 1.054e-09 2.369e-08
208 MESODERM DEVELOPMENT 10 118 1.085e-09 2.427e-08
209 UROGENITAL SYSTEM DEVELOPMENT 14 299 1.179e-09 2.624e-08
210 MITOTIC CELL CYCLE 21 766 1.211e-09 2.684e-08
211 REGULATION OF CELLULAR COMPONENT BIOGENESIS 21 767 1.24e-09 2.734e-08
212 COCHLEA MORPHOGENESIS 6 21 1.293e-09 2.837e-08
213 REGULATION OF CELLULAR COMPONENT MOVEMENT 21 771 1.361e-09 2.973e-08
214 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 10 121 1.389e-09 3.02e-08
215 STEM CELL PROLIFERATION 8 60 1.404e-09 3.038e-08
216 MESENCHYME MORPHOGENESIS 7 38 1.467e-09 3.16e-08
217 LOCOMOTION 25 1114 1.582e-09 3.392e-08
218 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 13 258 1.98e-09 4.226e-08
219 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 15 370 2.084e-09 4.429e-08
220 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 11 166 2.135e-09 4.495e-08
221 INNER EAR MORPHOGENESIS 9 92 2.127e-09 4.495e-08
222 MORPHOGENESIS OF A BRANCHING STRUCTURE 11 167 2.275e-09 4.768e-08
223 REGULATION OF MAP KINASE ACTIVITY 14 319 2.716e-09 5.667e-08
224 PROTEIN COMPLEX SUBUNIT ORGANIZATION 29 1527 2.767e-09 5.748e-08
225 MESODERM MORPHOGENESIS 8 66 3.065e-09 6.339e-08
226 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 17 514 3.512e-09 7.232e-08
227 POSITIVE REGULATION OF CELL PROLIFERATION 21 814 3.567e-09 7.311e-08
228 CELLULAR COMPONENT DISASSEMBLY 17 515 3.616e-09 7.379e-08
229 MORPHOGENESIS OF AN EPITHELIAL SHEET 7 43 3.661e-09 7.438e-08
230 EYE MORPHOGENESIS 10 136 4.355e-09 8.811e-08
231 POSITIVE REGULATION OF CELL CYCLE 14 332 4.529e-09 9.122e-08
232 IMMUNE SYSTEM PROCESS 33 1984 4.638e-09 9.301e-08
233 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 6 26 5.363e-09 1.071e-07
234 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 13 282 5.788e-09 1.151e-07
235 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 103 5.842e-09 1.157e-07
236 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 9 104 6.366e-09 1.255e-07
237 REGULATION OF EPITHELIAL CELL PROLIFERATION 13 285 6.57e-09 1.29e-07
238 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 15 404 6.839e-09 1.336e-07
239 AXIS ELONGATION 6 27 6.864e-09 1.336e-07
240 CELL CELL SIGNALING 20 767 7.416e-09 1.438e-07
241 REPRODUCTIVE SYSTEM DEVELOPMENT 15 408 7.805e-09 1.507e-07
242 DIGESTIVE SYSTEM DEVELOPMENT 10 148 9.873e-09 1.898e-07
243 REGULATION OF CELL ADHESION 18 629 1.111e-08 2.127e-07
244 FOREBRAIN DEVELOPMENT 14 357 1.138e-08 2.171e-07
245 REGULATION OF GROWTH 18 633 1.225e-08 2.321e-07
246 EAR MORPHOGENESIS 9 112 1.227e-08 2.321e-07
247 NEGATIVE REGULATION OF CELL PROLIFERATION 18 643 1.558e-08 2.935e-07
248 RESPONSE TO DRUG 15 431 1.622e-08 3.044e-07
249 KIDNEY MORPHOGENESIS 8 82 1.768e-08 3.303e-07
250 LEUKOCYTE CELL CELL ADHESION 12 255 1.839e-08 3.424e-07
251 IN UTERO EMBRYONIC DEVELOPMENT 13 311 1.857e-08 3.443e-07
252 POSITIVE REGULATION OF MAP KINASE ACTIVITY 11 207 2.145e-08 3.961e-07
253 IMMUNE SYSTEM DEVELOPMENT 17 582 2.202e-08 4.051e-07
254 POSITIVE REGULATION OF HYDROLASE ACTIVITY 21 905 2.262e-08 4.143e-07
255 OUTFLOW TRACT MORPHOGENESIS 7 56 2.483e-08 4.531e-07
256 RESPONSE TO ACID CHEMICAL 13 319 2.507e-08 4.556e-07
257 REGULATION OF CHROMATIN BINDING 5 17 2.822e-08 5.109e-07
258 RESPONSE TO ORGANIC CYCLIC COMPOUND 21 917 2.836e-08 5.115e-07
259 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 22 1008 2.963e-08 5.323e-07
260 REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 34 3.022e-08 5.408e-07
261 REGULATION OF STEM CELL PROLIFERATION 8 88 3.101e-08 5.528e-07
262 KIDNEY EPITHELIUM DEVELOPMENT 9 125 3.217e-08 5.713e-07
263 APPENDAGE DEVELOPMENT 10 169 3.514e-08 6.193e-07
264 LIMB DEVELOPMENT 10 169 3.514e-08 6.193e-07
265 REGULATION OF CELL GROWTH 14 391 3.561e-08 6.253e-07
266 MESONEPHROS DEVELOPMENT 8 90 3.706e-08 6.482e-07
267 REGULATION OF CELL SUBSTRATE ADHESION 10 173 4.387e-08 7.645e-07
268 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 9 131 4.838e-08 8.4e-07
269 WOUND HEALING 15 470 5.083e-08 8.792e-07
270 LYMPHOCYTE ACTIVATION 13 342 5.671e-08 9.772e-07
271 REGULATION OF MUSCLE ADAPTATION 7 63 5.738e-08 9.852e-07
272 COCHLEA DEVELOPMENT 6 39 7.167e-08 1.226e-06
273 LEUKOCYTE ACTIVATION 14 414 7.229e-08 1.232e-06
274 RESPONSE TO CYTOKINE 18 714 7.631e-08 1.296e-06
275 LENS DEVELOPMENT IN CAMERA TYPE EYE 7 66 7.967e-08 1.348e-06
276 MUSCLE CELL DIFFERENTIATION 11 237 8.573e-08 1.445e-06
277 RESPONSE TO WOUNDING 16 563 8.675e-08 1.457e-06
278 CAMERA TYPE EYE MORPHOGENESIS 8 101 9.186e-08 1.538e-06
279 EPITHELIAL CELL DIFFERENTIATION 15 495 9.979e-08 1.664e-06
280 REGULATION OF MUSCLE TISSUE DEVELOPMENT 8 103 1.071e-07 1.767e-06
281 REGULATION OF CIRCADIAN RHYTHM 8 103 1.071e-07 1.767e-06
282 REGULATION OF MUSCLE ORGAN DEVELOPMENT 8 103 1.071e-07 1.767e-06
283 RESPONSE TO ALCOHOL 13 362 1.097e-07 1.804e-06
284 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 22 1087 1.116e-07 1.828e-06
285 POSITIVE REGULATION OF PROTEIN IMPORT 8 104 1.155e-07 1.885e-06
286 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 10 192 1.17e-07 1.897e-06
287 BLOOD VESSEL MORPHOGENESIS 13 364 1.169e-07 1.897e-06
288 SOMATIC STEM CELL DIVISION 5 22 1.175e-07 1.898e-06
289 NEURAL PRECURSOR CELL PROLIFERATION 7 70 1.204e-07 1.939e-06
290 NEGATIVE REGULATION OF CELL DEVELOPMENT 12 303 1.219e-07 1.949e-06
291 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 12 303 1.219e-07 1.949e-06
292 FAT CELL DIFFERENTIATION 8 106 1.34e-07 2.135e-06
293 EMBRYONIC HEART TUBE DEVELOPMENT 7 73 1.615e-07 2.564e-06
294 CELL CYCLE PHASE TRANSITION 11 255 1.795e-07 2.832e-06
295 SKELETAL SYSTEM MORPHOGENESIS 10 201 1.794e-07 2.832e-06
296 RESPONSE TO ABIOTIC STIMULUS 21 1024 1.83e-07 2.876e-06
297 POSITIVE REGULATION OF TRANSPORT 20 936 1.953e-07 3.06e-06
298 PEPTIDYL THREONINE MODIFICATION 6 46 1.994e-07 3.113e-06
299 REGULATION OF OSTEOBLAST DIFFERENTIATION 8 112 2.055e-07 3.198e-06
300 BIOLOGICAL ADHESION 21 1032 2.082e-07 3.229e-06
301 REGULATION OF CELLULAR RESPONSE TO HEAT 7 76 2.137e-07 3.304e-06
302 PROTEIN COMPLEX BIOGENESIS 22 1132 2.248e-07 3.453e-06
303 PROTEIN COMPLEX ASSEMBLY 22 1132 2.248e-07 3.453e-06
304 REGULATION OF CELL CYCLE PHASE TRANSITION 12 321 2.27e-07 3.475e-06
305 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 7 77 2.34e-07 3.57e-06
306 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 262 2.355e-07 3.582e-06
307 CELLULAR RESPONSE TO ABIOTIC STIMULUS 11 263 2.447e-07 3.709e-06
308 CELL CELL ADHESION 16 608 2.457e-07 3.712e-06
309 ANTERIOR POSTERIOR AXIS SPECIFICATION 6 48 2.589e-07 3.898e-06
310 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 19 867 2.804e-07 4.209e-06
311 SKIN DEVELOPMENT 10 211 2.815e-07 4.212e-06
312 SPECIFICATION OF SYMMETRY 8 117 2.88e-07 4.268e-06
313 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 11 2.878e-07 4.268e-06
314 MAMMARY GLAND DEVELOPMENT 8 117 2.88e-07 4.268e-06
315 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 14 465 2.982e-07 4.405e-06
316 CELLULAR RESPONSE TO STRESS 26 1565 3.177e-07 4.679e-06
317 PROTEASOMAL PROTEIN CATABOLIC PROCESS 11 271 3.3e-07 4.844e-06
318 NEURON PROJECTION DEVELOPMENT 15 545 3.429e-07 5.018e-06
319 DEVELOPMENTAL INDUCTION 5 27 3.522e-07 5.137e-06
320 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 8 122 3.975e-07 5.78e-06
321 PROTEIN LOCALIZATION 28 1805 4.068e-07 5.897e-06
322 REGULATION OF NEURON DIFFERENTIATION 15 554 4.221e-07 6.099e-06
323 RESPONSE TO INORGANIC SUBSTANCE 14 479 4.261e-07 6.139e-06
324 REGULATION OF PROTEIN STABILITY 10 221 4.314e-07 6.196e-06
325 NEGATIVE REGULATION OF CELL GROWTH 9 170 4.506e-07 6.452e-06
326 REGULATION OF CELL PROJECTION ORGANIZATION 15 558 4.623e-07 6.598e-06
327 MAMMARY GLAND EPITHELIUM DEVELOPMENT 6 53 4.735e-07 6.717e-06
328 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 9 171 4.735e-07 6.717e-06
329 STEM CELL DIVISION 5 29 5.135e-07 7.263e-06
330 REGULATION OF CYTOKINE PRODUCTION 15 563 5.174e-07 7.295e-06
331 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 8 129 6.094e-07 8.567e-06
332 REGULATION OF OSSIFICATION 9 178 6.635e-07 9.299e-06
333 CALCIUM MEDIATED SIGNALING 7 90 6.853e-07 9.575e-06
334 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 5 31 7.283e-07 1.015e-05
335 NEGATIVE REGULATION OF GROWTH 10 236 7.868e-07 1.093e-05
336 REGULATION OF APOPTOTIC SIGNALING PATHWAY 12 363 8.384e-07 1.161e-05
337 NEGATIVE REGULATION OF CELL CYCLE 13 433 8.418e-07 1.162e-05
338 POSITIVE REGULATION OF GROWTH 10 238 8.497e-07 1.17e-05
339 REGULATION OF ORGAN FORMATION 5 32 8.593e-07 1.18e-05
340 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 13 437 9.329e-07 1.277e-05
341 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 95 9.907e-07 1.348e-05
342 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 7 95 9.907e-07 1.348e-05
343 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 5 33 1.008e-06 1.368e-05
344 POSITIVE REGULATION OF CYTOKINE PRODUCTION 12 370 1.024e-06 1.386e-05
345 EMBRYONIC DIGIT MORPHOGENESIS 6 61 1.105e-06 1.49e-05
346 RESPONSE TO NITROGEN COMPOUND 18 859 1.144e-06 1.535e-05
347 PROTEIN DEPHOSPHORYLATION 9 190 1.145e-06 1.535e-05
348 BRAIN MORPHOGENESIS 5 34 1.177e-06 1.574e-05
349 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 15 602 1.196e-06 1.595e-05
350 EMBRYONIC HEART TUBE MORPHOGENESIS 6 62 1.218e-06 1.619e-05
351 POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 7 98 1.224e-06 1.622e-05
352 NEURON DEVELOPMENT 16 687 1.238e-06 1.636e-05
353 PROTEIN AUTOPHOSPHORYLATION 9 192 1.249e-06 1.646e-05
354 PLATELET ACTIVATION 8 142 1.264e-06 1.661e-05
355 REGULATION OF CARTILAGE DEVELOPMENT 6 63 1.34e-06 1.756e-05
356 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 8 144 1.404e-06 1.835e-05
357 EAR DEVELOPMENT 9 195 1.42e-06 1.851e-05
358 SYNAPSE ORGANIZATION 8 145 1.479e-06 1.923e-05
359 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 4 16 1.553e-06 2.013e-05
360 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 15 616 1.591e-06 2.056e-05
361 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 22 1275 1.664e-06 2.145e-05
362 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 9 199 1.68e-06 2.16e-05
363 FOREBRAIN GENERATION OF NEURONS 6 66 1.768e-06 2.266e-05
364 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 14 541 1.801e-06 2.296e-05
365 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 14 541 1.801e-06 2.296e-05
366 REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 4 17 2.023e-06 2.565e-05
367 ESTABLISHMENT OF TISSUE POLARITY 4 17 2.023e-06 2.565e-05
368 REGULATION OF FAT CELL DIFFERENTIATION 7 106 2.078e-06 2.621e-05
369 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 7 106 2.078e-06 2.621e-05
370 REGULATION OF CELL JUNCTION ASSEMBLY 6 68 2.11e-06 2.654e-05
371 PALLIUM DEVELOPMENT 8 153 2.215e-06 2.778e-05
372 CELL PROJECTION ORGANIZATION 18 902 2.287e-06 2.86e-05
373 SYNAPSE ASSEMBLY 6 69 2.301e-06 2.87e-05
374 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 108 2.356e-06 2.932e-05
375 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 16 724 2.441e-06 3.029e-05
376 RESPONSE TO METAL ION 11 333 2.485e-06 3.076e-05
377 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 7 109 2.507e-06 3.094e-05
378 PERICARDIUM DEVELOPMENT 4 18 2.59e-06 3.179e-05
379 POST ANAL TAIL MORPHOGENESIS 4 18 2.59e-06 3.179e-05
380 POSITIVE REGULATION OF CELL MATRIX ADHESION 5 40 2.71e-06 3.319e-05
381 REGULATION OF NEURON PROJECTION DEVELOPMENT 12 408 2.827e-06 3.452e-05
382 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 5 41 3.073e-06 3.744e-05
383 SECOND MESSENGER MEDIATED SIGNALING 8 160 3.093e-06 3.758e-05
384 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 19 3.266e-06 3.958e-05
385 REGULATION OF CHROMOSOME ORGANIZATION 10 278 3.436e-06 4.152e-05
386 CELL MOTILITY 17 835 3.462e-06 4.163e-05
387 LOCALIZATION OF CELL 17 835 3.462e-06 4.163e-05
388 NEPHRON DEVELOPMENT 7 115 3.587e-06 4.301e-05
389 POSITIVE REGULATION OF LOCOMOTION 12 420 3.805e-06 4.552e-05
390 TONGUE DEVELOPMENT 4 20 4.065e-06 4.825e-05
391 TRACHEA DEVELOPMENT 4 20 4.065e-06 4.825e-05
392 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 20 4.065e-06 4.825e-05
393 REGULATION OF CYTOSKELETON ORGANIZATION 13 502 4.295e-06 5.086e-05
394 LABYRINTHINE LAYER DEVELOPMENT 5 44 4.395e-06 5.191e-05
395 REGULATION OF AXONOGENESIS 8 168 4.444e-06 5.235e-05
396 RENAL TUBULE DEVELOPMENT 6 78 4.735e-06 5.563e-05
397 REGULATION OF DEVELOPMENTAL GROWTH 10 289 4.845e-06 5.678e-05
398 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 21 5e-06 5.846e-05
399 TELENCEPHALON DEVELOPMENT 9 228 5.122e-06 5.974e-05
400 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 9 229 5.308e-06 6.148e-05
401 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 7 122 5.312e-06 6.148e-05
402 LEUKOCYTE DIFFERENTIATION 10 292 5.307e-06 6.148e-05
403 ANGIOGENESIS 10 293 5.469e-06 6.314e-05
404 REGULATION OF FIBROBLAST PROLIFERATION 6 81 5.902e-06 6.781e-05
405 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 9 232 5.898e-06 6.781e-05
406 JNK CASCADE 6 82 6.34e-06 7.265e-05
407 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 11 368 6.452e-06 7.376e-05
408 OSTEOBLAST DIFFERENTIATION 7 126 6.574e-06 7.479e-05
409 RESPONSE TO UV 7 126 6.574e-06 7.479e-05
410 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 5 48 6.809e-06 7.727e-05
411 MUSCLE CELL DEVELOPMENT 7 128 7.294e-06 8.237e-05
412 POSITIVE REGULATION OF OSSIFICATION 6 84 7.293e-06 8.237e-05
413 MACROMOLECULAR COMPLEX ASSEMBLY 22 1398 7.385e-06 8.32e-05
414 CARDIAC SEPTUM MORPHOGENESIS 5 49 7.549e-06 8.484e-05
415 CARDIAC SEPTUM DEVELOPMENT 6 85 7.812e-06 8.759e-05
416 POSITIVE REGULATION OF CELL ADHESION 11 376 7.904e-06 8.84e-05
417 REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 50 8.351e-06 9.318e-05
418 RESPONSE TO HORMONE 17 893 8.409e-06 9.36e-05
419 PROTEIN STABILIZATION 7 131 8.495e-06 9.434e-05
420 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 4 24 8.765e-06 9.687e-05
421 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 24 8.765e-06 9.687e-05
422 MAINTENANCE OF CELL NUMBER 7 132 8.93e-06 9.846e-05
423 NEGATIVE REGULATION OF TRANSPORT 12 458 9.151e-06 0.0001007
424 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 51 9.218e-06 0.0001012
425 REGULATION OF ACTIN FILAMENT BASED PROCESS 10 312 9.482e-06 0.0001038
426 CELL DIVISION 12 460 9.56e-06 0.0001044
427 POSITIVE REGULATION OF CELL CYCLE PROCESS 9 247 9.768e-06 0.0001064
428 EPITHELIAL CELL PROLIFERATION 6 89 1.02e-05 0.0001108
429 TAXIS 12 464 1.043e-05 0.0001131
430 ENDOTHELIUM DEVELOPMENT 6 90 1.087e-05 0.0001174
431 REGULATION OF CELL MATRIX ADHESION 6 90 1.087e-05 0.0001174
432 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 8 190 1.097e-05 0.0001182
433 OSSIFICATION 9 251 1.111e-05 0.0001194
434 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 5 53 1.116e-05 0.0001194
435 MESONEPHRIC TUBULE MORPHOGENESIS 5 53 1.116e-05 0.0001194
436 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 8 191 1.14e-05 0.0001216
437 CONNECTIVE TISSUE DEVELOPMENT 8 194 1.276e-05 0.0001359
438 NEPHRON EPITHELIUM DEVELOPMENT 6 93 1.313e-05 0.0001392
439 REGULATION OF DNA BINDING 6 93 1.313e-05 0.0001392
440 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 7 141 1.375e-05 0.0001454
441 RESPONSE TO LITHIUM ION 4 27 1.429e-05 0.0001504
442 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 1.429e-05 0.0001504
443 POSITIVE REGULATION OF IMMUNE RESPONSE 13 563 1.465e-05 0.0001539
444 NEURON PROJECTION MORPHOGENESIS 11 402 1.477e-05 0.0001548
445 CARDIAC CHAMBER DEVELOPMENT 7 144 1.576e-05 0.0001648
446 PEPTIDYL AMINO ACID MODIFICATION 16 841 1.607e-05 0.0001676
447 VENTRICULAR SEPTUM MORPHOGENESIS 4 28 1.66e-05 0.0001717
448 CELLULAR RESPONSE TO EXTERNAL STIMULUS 9 264 1.66e-05 0.0001717
449 GASTRULATION WITH MOUTH FORMING SECOND 4 28 1.66e-05 0.0001717
450 MORPHOGENESIS OF A POLARIZED EPITHELIUM 4 28 1.66e-05 0.0001717
451 RESPONSE TO EXTERNAL STIMULUS 25 1821 1.696e-05 0.000175
452 SEX DIFFERENTIATION 9 266 1.763e-05 0.0001815
453 CARTILAGE DEVELOPMENT 7 147 1.802e-05 0.0001851
454 POSITIVE REGULATION OF CELL GROWTH 7 148 1.883e-05 0.0001925
455 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 6 99 1.88e-05 0.0001925
456 VASCULOGENESIS 5 59 1.896e-05 0.0001935
457 NEURON PROJECTION GUIDANCE 8 205 1.902e-05 0.0001937
458 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 6 100 1.991e-05 0.0002022
459 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 5 60 2.06e-05 0.0002088
460 REGULATION OF GTPASE ACTIVITY 14 673 2.157e-05 0.0002182
461 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 8 209 2.186e-05 0.0002201
462 LYMPHOCYTE DIFFERENTIATION 8 209 2.186e-05 0.0002201
463 POSITIVE REGULATION OF STEM CELL PROLIFERATION 5 61 2.234e-05 0.0002245
464 NEGATIVE REGULATION OF PHOSPHORYLATION 11 422 2.313e-05 0.0002319
465 SYNAPTIC SIGNALING 11 424 2.415e-05 0.0002415
466 REGULATION OF SMOOTHENED SIGNALING PATHWAY 5 62 2.419e-05 0.0002415
467 CARDIAC CHAMBER MORPHOGENESIS 6 104 2.489e-05 0.000248
468 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 213 2.504e-05 0.0002489
469 ACTIVATION OF IMMUNE RESPONSE 11 427 2.577e-05 0.0002556
470 REGULATION OF EPIDERMIS DEVELOPMENT 5 63 2.616e-05 0.000259
471 CEREBRAL CORTEX DEVELOPMENT 6 105 2.628e-05 0.0002596
472 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 9 280 2.641e-05 0.0002601
473 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 7 156 2.644e-05 0.0002601
474 POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS 3 11 2.658e-05 0.0002609
475 NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 5 64 2.825e-05 0.0002768
476 EMBRYONIC FORELIMB MORPHOGENESIS 4 32 2.866e-05 0.0002802
477 NEGATIVE REGULATION OF AXONOGENESIS 5 65 3.047e-05 0.0002973
478 DEPHOSPHORYLATION 9 286 3.118e-05 0.0003035
479 EMBRYONIC EYE MORPHOGENESIS 4 33 3.248e-05 0.0003155
480 SOMATIC STEM CELL POPULATION MAINTENANCE 5 66 3.283e-05 0.0003175
481 CELLULAR RESPONSE TO UV 5 66 3.283e-05 0.0003175
482 POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 3 12 3.529e-05 0.0003388
483 TRACHEA MORPHOGENESIS 3 12 3.529e-05 0.0003388
484 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 3.529e-05 0.0003388
485 REGULATION OF SISTER CHROMATID SEGREGATION 5 67 3.532e-05 0.0003388
486 PROTEIN DESTABILIZATION 4 34 3.665e-05 0.0003502
487 NEURAL TUBE PATTERNING 4 34 3.665e-05 0.0003502
488 POSITIVE REGULATION OF AXONOGENESIS 5 69 4.074e-05 0.0003884
489 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 7 167 4.09e-05 0.0003892
490 BONE REMODELING 4 35 4.12e-05 0.0003913
491 REGULATION OF MEMBRANE PERMEABILITY 5 70 4.368e-05 0.0004139
492 CELLULAR RESPONSE TO ALCOHOL 6 115 4.393e-05 0.0004146
493 RESPONSE TO CALCIUM ION 6 115 4.393e-05 0.0004146
494 CHROMATIN MODIFICATION 12 539 4.544e-05 0.000427
495 HEMATOPOIETIC STEM CELL PROLIFERATION 3 13 4.57e-05 0.000427
496 REGULATION OF SKELETAL MUSCLE ADAPTATION 3 13 4.57e-05 0.000427
497 REGULATION OF CELL FATE SPECIFICATION 3 13 4.57e-05 0.000427
498 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 3 13 4.57e-05 0.000427
499 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 8 232 4.598e-05 0.0004281
500 CELLULAR MACROMOLECULE LOCALIZATION 19 1234 4.6e-05 0.0004281
501 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 4 36 4.616e-05 0.0004287
502 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 5 71 4.678e-05 0.000431
503 SKIN EPIDERMIS DEVELOPMENT 5 71 4.678e-05 0.000431
504 ENDODERM DEVELOPMENT 5 71 4.678e-05 0.000431
505 CELL FATE SPECIFICATION 5 71 4.678e-05 0.000431
506 REGULATION OF VASCULATURE DEVELOPMENT 8 233 4.739e-05 0.0004358
507 ENDOTHELIAL CELL DIFFERENTIATION 5 72 5.005e-05 0.0004594
508 STRIATED MUSCLE CELL DIFFERENTIATION 7 173 5.119e-05 0.0004689
509 REGULATION OF MUSCLE HYPERTROPHY 4 37 5.153e-05 0.0004711
510 POSITIVE REGULATION OF NEURON DIFFERENTIATION 9 306 5.27e-05 0.0004808
511 POSITIVE REGULATION OF PROTEIN BINDING 5 73 5.35e-05 0.0004862
512 PANCREAS DEVELOPMENT 5 73 5.35e-05 0.0004862
513 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 15 829 5.376e-05 0.0004876
514 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 7 175 5.506e-05 0.0004984
515 CELL MIGRATION INVOLVED IN GASTRULATION 3 14 5.792e-05 0.0005213
516 EMBRYONIC SKELETAL JOINT DEVELOPMENT 3 14 5.792e-05 0.0005213
517 REGULATION OF MONOCYTE DIFFERENTIATION 3 14 5.792e-05 0.0005213
518 MITOCHONDRIAL TRANSPORT 7 177 5.916e-05 0.0005314
519 HEMOSTASIS 9 311 5.97e-05 0.0005353
520 NEURAL CREST CELL DIFFERENTIATION 5 75 6.093e-05 0.0005452
521 T CELL DIFFERENTIATION 6 123 6.4e-05 0.0005716
522 REGULATION OF BMP SIGNALING PATHWAY 5 77 6.914e-05 0.0006163
523 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 8 246 6.94e-05 0.0006175
524 FORELIMB MORPHOGENESIS 4 40 7.04e-05 0.0006251
525 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 7.211e-05 0.0006379
526 REGULATION OF MESODERM DEVELOPMENT 3 15 7.211e-05 0.0006379
527 REGULATION OF MYELOID CELL DIFFERENTIATION 7 183 7.299e-05 0.0006445
528 POSITIVE REGULATION OF BINDING 6 127 7.648e-05 0.000674
529 NEGATIVE REGULATION OF KINASE ACTIVITY 8 250 7.767e-05 0.0006832
530 CELL JUNCTION ORGANIZATION 7 185 7.815e-05 0.0006861
531 CHROMATIN ORGANIZATION 13 663 7.903e-05 0.0006925
532 HEPATICOBILIARY SYSTEM DEVELOPMENT 6 128 7.988e-05 0.0006947
533 COGNITION 8 251 7.987e-05 0.0006947
534 REGULATION OF PHOSPHATASE ACTIVITY 6 128 7.988e-05 0.0006947
535 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 6 128 7.988e-05 0.0006947
536 EPITHELIAL CELL DEVELOPMENT 7 186 8.084e-05 0.0007018
537 EPIDERMIS DEVELOPMENT 8 253 8.44e-05 0.0007313
538 MORPHOGENESIS OF AN ENDOTHELIUM 3 16 8.839e-05 0.0007617
539 ORGAN INDUCTION 3 16 8.839e-05 0.0007617
540 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 3 16 8.839e-05 0.0007617
541 REPRODUCTION 19 1297 8.946e-05 0.0007695
542 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 4 43 9.386e-05 0.0008013
543 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 43 9.386e-05 0.0008013
544 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 4 43 9.386e-05 0.0008013
545 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 4 43 9.386e-05 0.0008013
546 HAIR CYCLE 5 83 9.896e-05 0.0008402
547 EMBRYONIC PLACENTA DEVELOPMENT 5 83 9.896e-05 0.0008402
548 MOLTING CYCLE 5 83 9.896e-05 0.0008402
549 RESPONSE TO RADIATION 10 413 0.000102 0.0008641
550 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 4 44 0.0001028 0.0008697
551 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 5 84 0.0001048 0.0008831
552 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 5 84 0.0001048 0.0008831
553 CELLULAR RESPONSE TO LITHIUM ION 3 17 0.0001069 0.0008962
554 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 3 17 0.0001069 0.0008962
555 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 3 17 0.0001069 0.0008962
556 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 6 135 0.0001072 0.0008973
557 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 7 195 0.0001086 0.0009057
558 REGULATION OF MUSCLE SYSTEM PROCESS 7 195 0.0001086 0.0009057
559 NEGATIVE REGULATION OF LOCOMOTION 8 263 0.0001104 0.0009192
560 REGULATION OF CHROMOSOME SEGREGATION 5 85 0.0001108 0.0009208
561 THYMOCYTE AGGREGATION 4 45 0.0001124 0.0009302
562 T CELL DIFFERENTIATION IN THYMUS 4 45 0.0001124 0.0009302
563 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 7 197 0.0001157 0.0009565
564 CELLULAR RESPONSE TO NITROGEN COMPOUND 11 505 0.0001162 0.0009575
565 CELLULAR RESPONSE TO RADIATION 6 137 0.0001163 0.0009575
566 REGULATION OF DNA METABOLIC PROCESS 9 340 0.0001178 0.0009681
567 CELL CYCLE G2 M PHASE TRANSITION 6 138 0.000121 0.0009912
568 PLACENTA DEVELOPMENT 6 138 0.000121 0.0009912
569 REGULATION OF CHONDROCYTE DIFFERENTIATION 4 46 0.0001225 0.001002
570 MITOTIC CELL CYCLE CHECKPOINT 6 139 0.0001259 0.001028
571 REGULATION OF CELL MATURATION 3 18 0.0001278 0.001037
572 UTERUS DEVELOPMENT 3 18 0.0001278 0.001037
573 SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION 3 18 0.0001278 0.001037
574 REGULATION OF SYNAPTIC PLASTICITY 6 140 0.0001309 0.001061
575 COVALENT CHROMATIN MODIFICATION 9 345 0.0001315 0.001064
576 REGULATION OF CELL DIVISION 8 272 0.0001392 0.001124
577 NEGATIVE REGULATION OF CATABOLIC PROCESS 7 203 0.0001394 0.001124
578 ACTIVATION OF INNATE IMMUNE RESPONSE 7 204 0.0001437 0.001157
579 CELLULAR RESPONSE TO LIGHT STIMULUS 5 91 0.000153 0.00123
580 MUSCLE ORGAN DEVELOPMENT 8 277 0.0001577 0.001265
581 MITOCHONDRIAL MEMBRANE ORGANIZATION 5 92 0.0001611 0.00129
582 RESPONSE TO ESTRADIOL 6 146 0.0001647 0.001317
583 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 4 50 0.00017 0.001348
584 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 5 93 0.0001695 0.001348
585 RESPONSE TO LIGHT STIMULUS 8 280 0.0001698 0.001348
586 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.00017 0.001348
587 RHO PROTEIN SIGNAL TRANSDUCTION 4 50 0.00017 0.001348
588 RESPONSE TO MECHANICAL STIMULUS 7 210 0.0001718 0.00136
589 MALE SEX DIFFERENTIATION 6 148 0.0001774 0.001401
590 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 5 95 0.0001873 0.001477
591 REGULATION OF MUSCLE CELL DIFFERENTIATION 6 152 0.000205 0.001614
592 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 3 21 0.0002057 0.001614
593 BONE RESORPTION 3 21 0.0002057 0.001614
594 CELL PART MORPHOGENESIS 12 633 0.0002064 0.001617
595 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 4 53 0.0002134 0.001669
596 REGULATION OF MITOCHONDRION ORGANIZATION 7 218 0.0002161 0.001684
597 RESPONSE TO ESTROGEN 7 218 0.0002161 0.001684
598 AMEBOIDAL TYPE CELL MIGRATION 6 154 0.0002201 0.001712
599 VENTRICULAR SEPTUM DEVELOPMENT 4 54 0.0002295 0.001783
600 CEREBRAL CORTEX NEURON DIFFERENTIATION 3 22 0.0002373 0.001825
601 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 3 22 0.0002373 0.001825
602 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 3 22 0.0002373 0.001825
603 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 6 156 0.000236 0.001825
604 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 3 22 0.0002373 0.001825
605 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 0.0002373 0.001825
606 REGULATION OF KIDNEY DEVELOPMENT 4 55 0.0002464 0.001892
607 REGULATION OF EXTENT OF CELL GROWTH 5 101 0.0002494 0.001912
608 REGULATION OF DEPHOSPHORYLATION 6 158 0.0002528 0.001934
609 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 5 102 0.0002612 0.001995
610 SMAD PROTEIN SIGNAL TRANSDUCTION 4 56 0.0002643 0.002013
611 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 4 56 0.0002643 0.002013
612 REGULATION OF OSTEOBLAST PROLIFERATION 3 23 0.0002717 0.002063
613 SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 3 23 0.0002717 0.002063
614 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 103 0.0002733 0.002071
615 MODULATION OF SYNAPTIC TRANSMISSION 8 301 0.0002771 0.002096
616 REGENERATION 6 161 0.0002797 0.002113
617 MYOTUBE DIFFERENTIATION 4 57 0.000283 0.002131
618 APOPTOTIC MITOCHONDRIAL CHANGES 4 57 0.000283 0.002131
619 SYSTEM PROCESS 22 1785 0.0002873 0.002159
620 ODONTOGENESIS 5 105 0.0002988 0.002242
621 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 3 24 0.0003093 0.00231
622 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 3 24 0.0003093 0.00231
623 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 3 24 0.0003093 0.00231
624 REGULATION OF LEUKOCYTE DIFFERENTIATION 7 232 0.0003154 0.002352
625 REGULATION OF EPITHELIAL CELL MIGRATION 6 166 0.0003296 0.002454
626 NEGATIVE REGULATION OF CELL DIVISION 4 60 0.0003449 0.002552
627 RESPONSE TO OXYGEN LEVELS 8 311 0.0003449 0.002552
628 CHONDROCYTE DIFFERENTIATION 4 60 0.0003449 0.002552
629 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 4 60 0.0003449 0.002552
630 LENS FIBER CELL DIFFERENTIATION 3 25 0.0003501 0.002569
631 SPINDLE CHECKPOINT 3 25 0.0003501 0.002569
632 FOREBRAIN REGIONALIZATION 3 25 0.0003501 0.002569
633 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 25 0.0003501 0.002569
634 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 25 0.0003501 0.002569
635 RESPONSE TO HYDROGEN PEROXIDE 5 109 0.0003552 0.002603
636 PROTEIN CATABOLIC PROCESS 11 579 0.0003769 0.002757
637 CELL CYCLE G1 S PHASE TRANSITION 5 111 0.0003863 0.002817
638 G1 S TRANSITION OF MITOTIC CELL CYCLE 5 111 0.0003863 0.002817
639 DEVELOPMENTAL PROGRAMMED CELL DEATH 3 26 0.0003941 0.002855
640 POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 3 26 0.0003941 0.002855
641 HOMEOSTATIC PROCESS 18 1337 0.0003945 0.002855
642 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 3 26 0.0003941 0.002855
643 REGULATION OF CELL FATE COMMITMENT 3 26 0.0003941 0.002855
644 REGULATION OF CELL SIZE 6 172 0.0003983 0.002878
645 SIGNAL RELEASE 6 173 0.0004108 0.002963
646 REGULATION OF MICROTUBULE BASED PROCESS 7 243 0.0004168 0.003002
647 REGULATION OF ENDOTHELIAL CELL MIGRATION 5 114 0.0004367 0.00314
648 SKELETAL MUSCLE TISSUE REGENERATION 3 27 0.0004416 0.003161
649 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 3 27 0.0004416 0.003161
650 NEGATIVE REGULATION OF AXON GUIDANCE 3 27 0.0004416 0.003161
651 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 12 689 0.0004446 0.003178
652 SINGLE ORGANISM CELLULAR LOCALIZATION 14 898 0.0004483 0.0032
653 RESPONSE TO STEROID HORMONE 10 497 0.0004494 0.003203
654 MEMBRANE ORGANIZATION 14 899 0.0004533 0.003225
655 RESPONSE TO INTERLEUKIN 1 5 115 0.0004545 0.003229
656 CHROMOSOME ORGANIZATION 15 1009 0.0004571 0.003242
657 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 5 117 0.0004919 0.003468
658 PLACENTA BLOOD VESSEL DEVELOPMENT 3 28 0.0004926 0.003468
659 NEGATIVE REGULATION OF CHROMOSOME SEGREGATION 3 28 0.0004926 0.003468
660 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 3 28 0.0004926 0.003468
661 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 3 28 0.0004926 0.003468
662 NEGATIVE REGULATION OF PROTEOLYSIS 8 329 0.0005008 0.00352
663 REGULATION OF SECRETION 12 699 0.0005054 0.003547
664 REGULATION OF CHEMOTAXIS 6 180 0.0005068 0.003552
665 REGULATION OF BODY FLUID LEVELS 10 506 0.0005168 0.003616
666 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 4 67 0.0005263 0.003671
667 CELLULAR RESPONSE TO DRUG 4 67 0.0005263 0.003671
668 RESPONSE TO KETONE 6 182 0.0005373 0.003742
669 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 3 29 0.0005473 0.003784
670 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 3 29 0.0005473 0.003784
671 REGULATION OF HEART MORPHOGENESIS 3 29 0.0005473 0.003784
672 EMBRYONIC HINDLIMB MORPHOGENESIS 3 29 0.0005473 0.003784
673 NEUROBLAST PROLIFERATION 3 29 0.0005473 0.003784
674 CELLULAR RESPONSE TO CYTOKINE STIMULUS 11 606 0.0005518 0.003806
675 REGULATION OF DENDRITE DEVELOPMENT 5 120 0.0005522 0.003806
676 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 4 68 0.0005568 0.003827
677 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 4 68 0.0005568 0.003827
678 REGULATION OF PEPTIDE TRANSPORT 7 256 0.0005686 0.003902
679 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 5 121 0.0005735 0.00393
680 POSITIVE REGULATION OF DNA METABOLIC PROCESS 6 185 0.0005856 0.004007
681 CELLULAR RESPONSE TO INTERFERON GAMMA 5 122 0.0005954 0.004068
682 BEHAVIOR 10 516 0.0006013 0.004103
683 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 3 30 0.0006056 0.004108
684 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 30 0.0006056 0.004108
685 ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 30 0.0006056 0.004108
686 MYOTUBE CELL DEVELOPMENT 3 30 0.0006056 0.004108
687 POSITIVE REGULATION OF MITOTIC CELL CYCLE 5 123 0.0006179 0.004185
688 MUSCLE ORGAN MORPHOGENESIS 4 70 0.0006216 0.004198
689 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 4 70 0.0006216 0.004198
690 MYELOID CELL DIFFERENTIATION 6 189 0.0006551 0.004418
691 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 5 126 0.0006893 0.004641
692 REGULATION OF NEURON APOPTOTIC PROCESS 6 192 0.0007114 0.004783
693 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 73 0.0007285 0.004891
694 PATTERNING OF BLOOD VESSELS 3 32 0.0007339 0.004921
695 CELL CYCLE CHECKPOINT 6 194 0.0007509 0.005027
696 REGULATION OF DENDRITE MORPHOGENESIS 4 74 0.0007669 0.00509
697 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 74 0.0007669 0.00509
698 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 8 351 0.0007645 0.00509
699 REGULATION OF REPRODUCTIVE PROCESS 5 129 0.0007667 0.00509
700 CELL JUNCTION ASSEMBLY 5 129 0.0007667 0.00509
701 CELL CELL JUNCTION ASSEMBLY 4 74 0.0007669 0.00509
702 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 8 352 0.0007787 0.005161
703 ESTABLISHMENT OF PROTEIN LOCALIZATION 18 1423 0.0008214 0.005437
704 REGULATION OF INNATE IMMUNE RESPONSE 8 357 0.000853 0.005638
705 MUSCLE TISSUE DEVELOPMENT 7 275 0.0008663 0.005718
706 FOREBRAIN NEURON DEVELOPMENT 3 34 0.0008783 0.005764
707 REGULATION OF PROTEIN DEACETYLATION 3 34 0.0008783 0.005764
708 ORGAN FORMATION 3 34 0.0008783 0.005764
709 NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION 3 34 0.0008783 0.005764
710 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 16 1193 0.0008917 0.005844
711 ACTIN FILAMENT BASED PROCESS 9 450 0.0009099 0.005955
712 ACTIVATION OF PROTEIN KINASE ACTIVITY 7 279 0.0009423 0.006158
713 REGULATION OF GASTRULATION 3 35 0.0009568 0.006227
714 RESPONSE TO MINERALOCORTICOID 3 35 0.0009568 0.006227
715 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 3 35 0.0009568 0.006227
716 POSITIVE REGULATION OF DEFENSE RESPONSE 8 364 0.0009666 0.006282
717 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 5 136 0.0009723 0.00631
718 HINDBRAIN DEVELOPMENT 5 137 0.001005 0.006511
719 CELLULAR RESPONSE TO HORMONE STIMULUS 10 552 0.001006 0.006511
720 PROTEOLYSIS 16 1208 0.001017 0.006575
721 CELLULAR RESPONSE TO MECHANICAL STIMULUS 4 80 0.001028 0.006632
722 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 3 36 0.00104 0.006691
723 HEAD MORPHOGENESIS 3 36 0.00104 0.006691
724 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 207 0.001051 0.006754
725 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 4 81 0.001076 0.006908
726 HINDLIMB MORPHOGENESIS 3 37 0.001127 0.007172
727 MYOBLAST DIFFERENTIATION 3 37 0.001127 0.007172
728 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 37 0.001127 0.007172
729 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 3 37 0.001127 0.007172
730 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 3 37 0.001127 0.007172
731 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 3 37 0.001127 0.007172
732 ENDOMEMBRANE SYSTEM ORGANIZATION 9 465 0.001144 0.007272
733 APOPTOTIC SIGNALING PATHWAY 7 289 0.001156 0.007336
734 REGULATION OF PROTEIN COMPLEX ASSEMBLY 8 375 0.001169 0.007413
735 NIK NF KAPPAB SIGNALING 4 83 0.001179 0.007463
736 NEGATIVE REGULATION OF AXON EXTENSION 3 38 0.001218 0.007672
737 RAS PROTEIN SIGNAL TRANSDUCTION 5 143 0.001217 0.007672
738 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 3 38 0.001218 0.007672
739 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 5 143 0.001217 0.007672
740 RESPONSE TO INTERFERON GAMMA 5 144 0.001255 0.00789
741 REGULATION OF CELL CELL ADHESION 8 380 0.001272 0.007988
742 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 4 85 0.001288 0.008066
743 EPHRIN RECEPTOR SIGNALING PATHWAY 4 85 0.001288 0.008066
744 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 6 216 0.001307 0.008176
745 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 3 39 0.001315 0.008178
746 NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 3 39 0.001315 0.008178
747 REGULATION OF AXON GUIDANCE 3 39 0.001315 0.008178
748 TRABECULA MORPHOGENESIS 3 39 0.001315 0.008178
749 T CELL RECEPTOR SIGNALING PATHWAY 5 146 0.001334 0.008276
750 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 5 146 0.001334 0.008276
751 SINGLE ORGANISM BEHAVIOR 8 384 0.001359 0.008422
752 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 5 147 0.001375 0.008507
753 REGULATION OF HORMONE LEVELS 9 478 0.001385 0.008556
754 TISSUE REMODELING 4 87 0.001404 0.008664
755 APICAL JUNCTION ASSEMBLY 3 40 0.001416 0.008701
756 REGULATION OF MEIOTIC CELL CYCLE 3 40 0.001416 0.008701
757 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 3 40 0.001416 0.008701
758 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 4 88 0.001465 0.008978
759 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 4 88 0.001465 0.008978
760 REGULATION OF CELL ACTIVATION 9 484 0.001509 0.009236
761 PROSTATE GLAND DEVELOPMENT 3 41 0.001521 0.009301
762 CALCIUM ION TRANSPORT 6 223 0.001538 0.009391
763 PROTEIN LOCALIZATION TO CELL PERIPHERY 5 151 0.001548 0.009429
764 REGULATION OF PEPTIDASE ACTIVITY 8 392 0.001548 0.009429
765 REGULATION OF CHROMATIN ORGANIZATION 5 152 0.001594 0.009694
766 BONE TRABECULA MORPHOGENESIS 2 11 0.001625 0.009771
767 REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 2 11 0.001625 0.009771
768 PRIMITIVE STREAK FORMATION 2 11 0.001625 0.009771
769 ENDOCARDIUM DEVELOPMENT 2 11 0.001625 0.009771
770 DENDRITE MORPHOGENESIS 3 42 0.001632 0.009771
771 CARDIAC CELL FATE COMMITMENT 2 11 0.001625 0.009771
772 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 3 42 0.001632 0.009771
773 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 42 0.001632 0.009771
774 EPITHELIAL CELL MORPHOGENESIS 3 42 0.001632 0.009771
775 GENITALIA DEVELOPMENT 3 42 0.001632 0.009771
776 OLFACTORY BULB INTERNEURON DEVELOPMENT 2 11 0.001625 0.009771
777 ENDOTHELIAL TUBE MORPHOGENESIS 2 11 0.001625 0.009771
NumGOOverlapSizeP ValueAdj. P Value
1 FRIZZLED BINDING 19 36 2.176e-34 2.021e-31
2 BETA CATENIN BINDING 21 84 1.426e-29 6.622e-27
3 WNT PROTEIN BINDING 12 31 5.985e-20 1.441e-17
4 WNT ACTIVATED RECEPTOR ACTIVITY 11 22 6.203e-20 1.441e-17
5 ENZYME BINDING 41 1737 2.053e-16 3.814e-14
6 G PROTEIN COUPLED RECEPTOR BINDING 19 259 2.822e-16 4.369e-14
7 PROTEIN SERINE THREONINE KINASE ACTIVITY 22 445 4.016e-15 5.33e-13
8 PROTEIN DOMAIN SPECIFIC BINDING 23 624 4.371e-13 5.076e-11
9 PROTEIN KINASE ACTIVITY 23 640 7.376e-13 7.614e-11
10 TRANSCRIPTION FACTOR BINDING 21 524 1.067e-12 9.908e-11
11 RECEPTOR BINDING 33 1476 1.964e-12 1.659e-10
12 KINASE BINDING 21 606 1.665e-11 1.289e-09
13 ARMADILLO REPEAT DOMAIN BINDING 6 13 4.238e-11 3.029e-09
14 KINASE ACTIVITY 23 842 1.853e-10 1.209e-08
15 RECEPTOR AGONIST ACTIVITY 6 16 1.951e-10 1.209e-08
16 SMAD BINDING 9 72 2.285e-10 1.327e-08
17 SIGNAL TRANSDUCER ACTIVITY 32 1731 6.365e-10 3.39e-08
18 REGULATORY REGION NUCLEIC ACID BINDING 22 818 6.568e-10 3.39e-08
19 I SMAD BINDING 5 11 2.163e-09 1.058e-07
20 MOLECULAR FUNCTION REGULATOR 27 1353 3.91e-09 1.816e-07
21 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 23 992 4.366e-09 1.931e-07
22 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 9 104 6.366e-09 2.688e-07
23 CORE PROMOTER PROXIMAL REGION DNA BINDING 14 371 1.847e-08 7.462e-07
24 RECEPTOR ACTIVATOR ACTIVITY 6 32 2.055e-08 7.953e-07
25 UBIQUITIN LIKE PROTEIN LIGASE BINDING 12 264 2.7e-08 1.003e-06
26 PDZ DOMAIN BINDING 8 90 3.706e-08 1.324e-06
27 R SMAD BINDING 5 23 1.494e-07 5.141e-06
28 RECEPTOR REGULATOR ACTIVITY 6 45 1.742e-07 5.778e-06
29 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 12 315 1.854e-07 5.938e-06
30 RHO GTPASE BINDING 7 78 2.559e-07 7.925e-06
31 PROTEIN DIMERIZATION ACTIVITY 22 1149 2.902e-07 8.697e-06
32 GAMMA CATENIN BINDING 4 12 4.298e-07 1.248e-05
33 CALMODULIN BINDING 9 179 6.955e-07 1.958e-05
34 ACTIVATING TRANSCRIPTION FACTOR BINDING 6 57 7.351e-07 2.009e-05
35 MAP KINASE ACTIVITY 4 14 8.618e-07 2.287e-05
36 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 5 36 1.581e-06 4.079e-05
37 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 15 629 2.057e-06 5.165e-05
38 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 11 328 2.148e-06 5.251e-05
39 DOUBLE STRANDED DNA BINDING 16 764 4.849e-06 0.0001099
40 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 9 226 4.769e-06 0.0001099
41 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 14 588 4.723e-06 0.0001099
42 RECEPTOR SIGNALING PROTEIN ACTIVITY 8 172 5.288e-06 0.000117
43 CHROMATIN BINDING 12 435 5.441e-06 0.0001175
44 RIBONUCLEOTIDE BINDING 26 1860 7.983e-06 0.0001685
45 PROTEIN HOMODIMERIZATION ACTIVITY 15 722 1.086e-05 0.0002241
46 CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY 4 28 1.66e-05 0.0003353
47 ADENYL NUCLEOTIDE BINDING 22 1514 2.562e-05 0.0005063
48 PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 5 64 2.825e-05 0.0005468
49 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 19 1199 3.111e-05 0.0005898
50 IDENTICAL PROTEIN BINDING 19 1209 3.485e-05 0.0006429
51 CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY 3 12 3.529e-05 0.0006429
52 PHOSPHORIC ESTER HYDROLASE ACTIVITY 10 368 3.904e-05 0.0006975
53 TRANSCRIPTION COACTIVATOR ACTIVITY 9 296 4.075e-05 0.0007142
54 SEQUENCE SPECIFIC DNA BINDING 17 1037 5.642e-05 0.0009706
55 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 7 178 6.13e-05 0.001035
56 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING 3 15 7.211e-05 0.001196
57 ENZYME REGULATOR ACTIVITY 16 959 7.774e-05 0.001267
58 PROTEIN KINASE C ACTIVITY 3 16 8.839e-05 0.001416
59 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 5 92 0.0001611 0.002537
60 ENHANCER BINDING 5 93 0.0001695 0.002625
61 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 3 21 0.0002057 0.003133
62 GTPASE BINDING 8 295 0.0002419 0.003625
63 MITOGEN ACTIVATED PROTEIN KINASE BINDING 3 24 0.0003093 0.004561
64 HORMONE RECEPTOR BINDING 6 168 0.0003513 0.0051
65 BHLH TRANSCRIPTION FACTOR BINDING 3 28 0.0004926 0.006934
66 CADHERIN BINDING 3 28 0.0004926 0.006934
67 P53 BINDING 4 67 0.0005263 0.007297
68 PHOSPHOLIPASE C ACTIVITY 3 31 0.0006678 0.009123
NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALOSOME 9 11 1.955e-19 1.142e-16
2 BETA CATENIN DESTRUCTION COMPLEX 9 14 7.019e-18 2.05e-15
3 ENDOCYTIC VESICLE MEMBRANE 12 152 4.95e-11 9.636e-09
4 PHOSPHATASE COMPLEX 8 48 2.187e-10 3.193e-08
5 LATERAL PLASMA MEMBRANE 8 50 3.083e-10 3.601e-08
6 ENDOCYTIC VESICLE 13 256 1.801e-09 1.753e-07
7 SYNAPSE 20 754 5.559e-09 4.638e-07
8 TRANSCRIPTION FACTOR COMPLEX 13 298 1.119e-08 8.169e-07
9 CATALYTIC COMPLEX 22 1038 4.978e-08 3.23e-06
10 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 5 20 6.976e-08 4.074e-06
11 INTRACELLULAR VESICLE 24 1259 8.148e-08 4.326e-06
12 PROTEINACEOUS EXTRACELLULAR MATRIX 13 356 9.04e-08 4.4e-06
13 CHROMOSOME 19 880 3.519e-07 1.581e-05
14 EXTRACELLULAR MATRIX 13 426 7.012e-07 2.73e-05
15 NUCLEAR CHROMATIN 11 291 6.681e-07 2.73e-05
16 CHROMATIN 13 441 1.033e-06 3.77e-05
17 SYNAPSE PART 15 610 1.409e-06 4.841e-05
18 CYTOSKELETAL PART 23 1436 3.271e-06 0.0001061
19 TRANSCRIPTIONAL REPRESSOR COMPLEX 6 74 3.477e-06 0.0001069
20 VESICLE MEMBRANE 13 512 5.317e-06 0.0001479
21 LAMELLIPODIUM 8 172 5.288e-06 0.0001479
22 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 7 127 6.926e-06 0.0001839
23 EXCITATORY SYNAPSE 8 197 1.427e-05 0.0003623
24 CYTOSKELETON 26 1967 2.146e-05 0.0005221
25 MICROTUBULE CYTOSKELETON 18 1068 2.305e-05 0.0005386
26 CYTOPLASMIC VESICLE PART 13 601 2.9e-05 0.0006513
27 CELL SURFACE 14 757 7.717e-05 0.001669
28 NUCLEAR ENVELOPE 10 416 0.0001082 0.002179
29 CELL PROJECTION 23 1786 0.0001059 0.002179
30 PROTEIN KINASE COMPLEX 5 90 0.0001453 0.002828
31 NUCLEAR CHROMOSOME 11 523 0.0001578 0.002972
32 NUCLEAR MEMBRANE 8 280 0.0001698 0.003098
33 GOLGI LUMEN 5 94 0.0001783 0.003155
34 NEURON PART 18 1265 0.0002014 0.00346
35 NEURONAL POSTSYNAPTIC DENSITY 4 53 0.0002134 0.003561
36 CELL PROJECTION PART 15 946 0.0002308 0.003744
37 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 5 101 0.0002494 0.003937
38 POSTSYNAPSE 9 378 0.0002595 0.003939
39 SOMATODENDRITIC COMPARTMENT 12 650 0.000263 0.003939
40 CELL CELL JUNCTION 9 383 0.0002858 0.004071
41 CYTOPLASMIC MICROTUBULE 4 57 0.000283 0.004071
42 CENTROSOME 10 487 0.0003833 0.00533
43 CHROMOSOME CENTROMERIC REGION 6 174 0.0004235 0.005752
44 CLATHRIN COATED ENDOCYTIC VESICLE 4 65 0.0004688 0.006223
45 MEMBRANE REGION 16 1134 0.0005173 0.006713
46 CELL JUNCTION 16 1151 0.0006078 0.007716
47 ACTIN FILAMENT 4 70 0.0006216 0.007723
48 CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 3 31 0.0006678 0.008125
49 MICROTUBULE ORGANIZING CENTER 11 623 0.0006934 0.008264
50 APICAL JUNCTION COMPLEX 5 128 0.0007402 0.008593
51 CELL LEADING EDGE 8 350 0.0007505 0.008593
52 PERINUCLEAR REGION OF CYTOPLASM 11 642 0.0008863 0.009766
53 SCF UBIQUITIN LIGASE COMPLEX 3 34 0.0008783 0.009766
54 DENDRITE 9 451 0.0009242 0.009995

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04310_Wnt_signaling_pathway 111 151 5.53e-261 9.95399999999999e-259
2 hsa04916_Melanogenesis 42 101 9.688e-71 8.719e-69
3 hsa04390_Hippo_signaling_pathway 46 154 9.597e-70 5.758e-68
4 hsa04340_Hedgehog_signaling_pathway 19 56 9.844e-30 4.43e-28
5 hsa04720_Long.term_potentiation 18 70 1.08e-25 3.887e-24
6 hsa04520_Adherens_junction 17 73 1.715e-23 5.145e-22
7 hsa04114_Oocyte_meiosis 18 114 1.534e-21 3.946e-20
8 hsa04662_B_cell_receptor_signaling_pathway 15 75 9.483e-20 2.134e-18
9 hsa04370_VEGF_signaling_pathway 15 76 1.176e-19 2.352e-18
10 hsa04010_MAPK_signaling_pathway 21 268 1.682e-18 3.028e-17
11 hsa04912_GnRH_signaling_pathway 15 101 1.1e-17 1.8e-16
12 hsa04360_Axon_guidance 16 130 1.908e-17 2.861e-16
13 hsa04510_Focal_adhesion 18 200 4.866e-17 6.738e-16
14 hsa04660_T_cell_receptor_signaling_pathway 14 108 1.024e-15 1.309e-14
15 hsa04650_Natural_killer_cell_mediated_cytotoxicity 15 136 1.091e-15 1.309e-14
16 hsa04350_TGF.beta_signaling_pathway 13 85 1.219e-15 1.371e-14
17 hsa04012_ErbB_signaling_pathway 13 87 1.673e-15 1.771e-14
18 hsa04020_Calcium_signaling_pathway 16 177 2.802e-15 2.802e-14
19 hsa04971_Gastric_acid_secretion 12 74 7.641e-15 7.239e-14
20 hsa04722_Neurotrophin_signaling_pathway 12 127 5.871e-12 5.283e-11
21 hsa04380_Osteoclast_differentiation 12 128 6.448e-12 5.527e-11
22 hsa04270_Vascular_smooth_muscle_contraction 11 116 4.486e-11 3.67e-10
23 hsa04110_Cell_cycle 11 128 1.314e-10 1.028e-09
24 hsa04730_Long.term_depression 9 70 1.762e-10 1.322e-09
25 hsa04062_Chemokine_signaling_pathway 12 189 6.235e-10 4.49e-09
26 hsa04530_Tight_junction 10 133 3.506e-09 2.427e-08
27 hsa04330_Notch_signaling_pathway 7 47 7.016e-09 4.677e-08
28 hsa04664_Fc_epsilon_RI_signaling_pathway 8 79 1.312e-08 8.432e-08
29 hsa04670_Leukocyte_transendothelial_migration 9 117 1.803e-08 1.119e-07
30 hsa04970_Salivary_secretion 8 89 3.392e-08 2.035e-07
31 hsa04540_Gap_junction 8 90 3.706e-08 2.152e-07
32 hsa04014_Ras_signaling_pathway 11 236 8.213e-08 4.62e-07
33 hsa04972_Pancreatic_secretion 8 101 9.186e-08 5.011e-07
34 hsa04151_PI3K_AKT_signaling_pathway 12 351 5.882e-07 3.114e-06
35 hsa04070_Phosphatidylinositol_signaling_system 6 78 4.735e-06 2.435e-05
36 hsa04710_Circadian_rhythm_._mammal 4 23 7.335e-06 3.668e-05
37 hsa04210_Apoptosis 6 89 1.02e-05 4.96e-05
38 hsa04620_Toll.like_receptor_signaling_pathway 6 102 2.228e-05 0.0001056
39 hsa04810_Regulation_of_actin_cytoskeleton 8 214 2.589e-05 0.0001195
40 hsa03015_mRNA_surveillance_pathway 5 83 9.896e-05 0.0004453
41 hsa04910_Insulin_signaling_pathway 6 138 0.000121 0.0005303
42 hsa04914_Progesterone.mediated_oocyte_maturation 5 87 0.0001237 0.0005303
43 hsa04666_Fc_gamma_R.mediated_phagocytosis 5 95 0.0001873 0.0007842
44 hsa04630_Jak.STAT_signaling_pathway 6 155 0.0002279 0.0009324
45 hsa04621_NOD.like_receptor_signaling_pathway 4 59 0.0003233 0.001293
46 hsa04622_RIG.I.like_receptor_signaling_pathway 4 71 0.0006559 0.002567
47 hsa04960_Aldosterone.regulated_sodium_reabsorption 3 42 0.001632 0.006249
48 hsa04742_Taste_transduction 3 52 0.003017 0.01132
49 hsa00562_Inositol_phosphate_metabolism 3 57 0.003916 0.01438
50 hsa04920_Adipocytokine_signaling_pathway 3 68 0.006418 0.0231
51 hsa04115_p53_signaling_pathway 3 69 0.006683 0.02359
52 hsa04141_Protein_processing_in_endoplasmic_reticulum 4 168 0.01436 0.04971
53 hsa04740_Olfactory_transduction 6 388 0.02118 0.07192
54 hsa04962_Vasopressin.regulated_water_reabsorption 2 44 0.02482 0.08122
55 hsa04973_Carbohydrate_digestion_and_absorption 2 44 0.02482 0.08122
56 hsa04120_Ubiquitin_mediated_proteolysis 3 139 0.04235 0.1361
57 hsa04976_Bile_secretion 2 71 0.05923 0.187
58 hsa03008_Ribosome_biogenesis_in_eukaryotes 2 81 0.07454 0.2313
59 hsa04144_Endocytosis 3 203 0.1036 0.316

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

TBX5-AS1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-421;hsa-miR-450b-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 19 PRICKLE2 Sponge network -2.108 0 -1.561 0 0.522
2

RP11-389C8.2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 24 CCND2 Sponge network -2.039 0 -1.641 0 0.52
3

LINC00702

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-421;hsa-miR-450b-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-628-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 23 PRICKLE2 Sponge network -2.856 0 -1.561 0 0.518
4 AF131215.2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-550a-5p;hsa-miR-589-3p 14 CCND2 Sponge network -2.09 0 -1.641 0 0.505
5

RP11-389C8.2

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-421;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 15 PRICKLE2 Sponge network -2.039 0 -1.561 0 0.493
6 RP11-750H9.5 hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-550a-5p;hsa-miR-877-5p 10 CCND2 Sponge network -1.959 0 -1.641 0 0.493
7

RP5-1042I8.7

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-421;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p 12 PRICKLE2 Sponge network -0.733 0.00018 -1.561 0 0.49
8

AC109642.1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-590-3p 12 PRICKLE2 Sponge network -2.791 0 -1.561 0 0.489
9

PCED1B-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-877-5p;hsa-miR-93-5p;hsa-miR-96-5p 18 CCND2 Sponge network -0.672 0.02084 -1.641 0 0.488
10

RP11-401P9.4

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-33a-5p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-589-5p;hsa-miR-590-5p 13 PRICKLE2 Sponge network -3.04 0 -1.561 0 0.479
11

RP11-1024P17.1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-628-5p;hsa-miR-629-3p 17 PRICKLE2 Sponge network -2.062 0 -1.561 0 0.478
12

MAGI2-AS3

 hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-21-3p;hsa-miR-25-3p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-92b-3p 11 CAMK2A Sponge network -1.892 0 -1.985 0 0.477
13

RP11-399O19.9

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-7-1-3p;hsa-miR-93-5p 18 CCND2 Sponge network -0.873 0.00072 -1.641 0 0.469
14

MAGI2-AS3

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-421;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 18 PRICKLE2 Sponge network -1.892 0 -1.561 0 0.461
15

AF131215.9

 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-450b-5p;hsa-miR-503-5p;hsa-miR-590-3p 13 CCND2 Sponge network -1.808 0 -1.641 0 0.46
16

BZRAP1-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-550a-5p;hsa-miR-877-5p 14 CCND2 Sponge network -0.785 0.00723 -1.641 0 0.456
17 LINC00996 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-320b;hsa-miR-550a-5p 10 CCND2 Sponge network -1.372 0.00025 -1.641 0 0.454
18

RP11-532F6.3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-301a-3p 13 CCND2 Sponge network -2.028 0 -1.641 0 0.445
19

LINC00968

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-33a-5p;hsa-miR-421;hsa-miR-450b-5p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p 18 PRICKLE2 Sponge network -4.19 0 -1.561 0 0.438
20

LINC00702

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-450b-5p;hsa-miR-501-5p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-660-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p;hsa-miR-96-5p 34 CCND2 Sponge network -2.856 0 -1.641 0 0.433
21

RP11-456K23.1

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-450b-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p 16 PRICKLE2 Sponge network -1.488 0 -1.561 0 0.432
22

LINC00472

 hsa-miR-130b-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-450b-5p;hsa-miR-7-1-3p 10 PRICKLE2 Sponge network -2.952 0 -1.561 0 0.411
23

CTD-2013N24.2

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 15 PRICKLE2 Sponge network -1.745 0 -1.561 0 0.409
24 RP11-474D1.3 hsa-let-7b-3p;hsa-miR-146a-5p;hsa-miR-146b-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-23a-3p;hsa-miR-27a-3p;hsa-miR-28-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-452-3p 12 FZD3 Sponge network 2.056 0.11938 0.793 0.00088 0.407
25

TBX5-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-450b-5p;hsa-miR-501-5p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-877-5p 26 CCND2 Sponge network -2.108 0 -1.641 0 0.404
26

FENDRR

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-450b-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 17 PRICKLE2 Sponge network -4.222 0 -1.561 0 0.404
27

AC011899.9

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 19 CCND2 Sponge network -2.611 0 -1.641 0 0.404
28

LINC00702

 hsa-miR-130b-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-21-3p;hsa-miR-25-3p;hsa-miR-582-3p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-92b-3p 11 CAMK2A Sponge network -2.856 0 -1.985 0 0.401
29

LINC00968

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-450b-5p;hsa-miR-503-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 27 CCND2 Sponge network -4.19 0 -1.641 0 0.396
30

RP11-720L2.4

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-93-5p 12 CCND2 Sponge network -2.305 0 -1.641 0 0.394
31

MIR497HG

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 17 PRICKLE2 Sponge network -2.142 0 -1.561 0 0.384
32

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-429;hsa-miR-501-5p;hsa-miR-503-5p;hsa-miR-590-3p;hsa-miR-660-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p 27 CCND2 Sponge network -1.892 0 -1.641 0 0.378
33

RP11-1024P17.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p 21 CCND2 Sponge network -2.062 0 -1.641 0 0.374
34

LINC00261

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-421;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 16 PRICKLE2 Sponge network -2.566 0.00025 -1.561 0 0.371
35

C1orf132

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-212-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-450b-5p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-629-3p 13 PRICKLE2 Sponge network -0.86 0.02429 -1.561 0 0.364
36

RP11-1008C21.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-550a-5p;hsa-miR-590-3p 17 CCND2 Sponge network -1.826 3.0E-5 -1.641 0 0.36
37

RP11-284N8.3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 20 CCND2 Sponge network -0.761 0.05061 -1.641 0 0.36
38 LINC00473 hsa-miR-146a-5p;hsa-miR-146b-5p;hsa-miR-155-5p;hsa-miR-16-1-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-342-3p;hsa-miR-361-5p;hsa-miR-452-3p;hsa-miR-452-5p 12 FZD3 Sponge network -0.765 0.56027 0.793 0.00088 0.356
39

CTD-2013N24.2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-501-5p;hsa-miR-590-3p;hsa-miR-660-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 24 CCND2 Sponge network -1.745 0 -1.641 0 0.354
40

RP11-389C8.2

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-429;hsa-miR-542-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 14 FZD4 Sponge network -2.039 0 -1.785 0 0.354
41

LINC00968

 hsa-miR-130b-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-2355-3p;hsa-miR-29a-5p;hsa-miR-590-3p;hsa-miR-9-5p 10 NFATC2 Sponge network -4.19 0 -1.179 0.0004 0.353
42

AC011526.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-450b-5p;hsa-miR-503-5p;hsa-miR-93-5p;hsa-miR-96-5p 10 CCND2 Sponge network -2.783 0 -1.641 0 0.352
43

RP11-378A13.1

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-629-3p 12 PRICKLE2 Sponge network -1.713 0 -1.561 0 0.352
44

LINC00961

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-628-5p 10 PRICKLE2 Sponge network -2.724 0 -1.561 0 0.351
45

FENDRR

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-301a-3p;hsa-miR-424-5p;hsa-miR-542-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-708-5p;hsa-miR-98-5p 13 FZD4 Sponge network -4.222 0 -1.785 0 0.348
46 CTD-2003C8.2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-550a-5p 11 CCND2 Sponge network -3.403 0 -1.641 0 0.345
47

RP11-354E11.2

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-628-5p;hsa-miR-629-3p 17 PRICKLE2 Sponge network -2.138 0 -1.561 0 0.344
48 AGAP11 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-330-5p;hsa-miR-421;hsa-miR-590-5p;hsa-miR-629-3p 11 PRICKLE2 Sponge network -2.127 0 -1.561 0 0.343
49

RP11-284N8.3

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-33a-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 12 PRICKLE2 Sponge network -0.761 0.05061 -1.561 0 0.341
50

GAS6-AS2

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-421;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 16 PRICKLE2 Sponge network -1.761 0 -1.561 0 0.341
51

HHIP-AS1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 12 PRICKLE2 Sponge network -2.807 0 -1.561 0 0.34
52 RP11-23P13.6 hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-20a-5p;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-590-3p;hsa-miR-877-5p 11 CCND2 Sponge network -0.705 0.00072 -1.641 0 0.34
53

AC109642.1

 hsa-miR-130b-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-2355-3p;hsa-miR-29a-5p;hsa-miR-590-3p;hsa-miR-9-5p 10 NFATC2 Sponge network -2.791 0 -1.179 0.0004 0.339
54

AC109642.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-96-5p 24 CCND2 Sponge network -2.791 0 -1.641 0 0.339
55

RP11-401P9.4

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-550a-5p;hsa-miR-590-5p;hsa-miR-93-5p 19 CCND2 Sponge network -3.04 0 -1.641 0 0.337
56

GAS6-AS2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 23 CCND2 Sponge network -1.761 0 -1.641 0 0.337
57

NR2F1-AS1

 hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-330-5p;hsa-miR-421;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 11 WNT5A Sponge network -0.427 0.1559 -0.372 0.19306 0.336
58

RP11-354E11.2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-590-3p;hsa-miR-96-5p 17 CCND2 Sponge network -2.138 0 -1.641 0 0.335
59

AC109642.1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-301a-3p;hsa-miR-424-5p;hsa-miR-590-3p 12 FZD4 Sponge network -2.791 0 -1.785 0 0.335
60

DNM3OS

 hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19b-3p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 10 PRICKLE2 Sponge network 0.053 0.85755 -1.561 0 0.333
61

RP11-1223D19.1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-942-5p 10 FBXW11 Sponge network -0.862 0.05389 -0.304 0.01022 0.331
62

RP11-456K23.1

 hsa-miR-106b-5p;hsa-miR-142-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-21-5p;hsa-miR-210-3p;hsa-miR-450b-5p;hsa-miR-589-3p;hsa-miR-590-3p 10 APC Sponge network -1.488 0 -0.814 0 0.328
63

LINC00472

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-450b-5p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 18 CCND2 Sponge network -2.952 0 -1.641 0 0.327
64 AC144831.1 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-20a-5p;hsa-miR-28-5p;hsa-miR-324-3p;hsa-miR-550a-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p 14 CCND2 Sponge network -2.063 0 -1.641 0 0.327
65

SH3RF3-AS1

 hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 12 PRICKLE2 Sponge network -1.583 0 -1.561 0 0.327
66

TBX5-AS1

 hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-29a-5p;hsa-miR-421;hsa-miR-576-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p 11 WNT5A Sponge network -2.108 0 -0.372 0.19306 0.323
67

MAGI2-AS3

 hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-29a-5p;hsa-miR-330-5p;hsa-miR-421;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 11 WNT5A Sponge network -1.892 0 -0.372 0.19306 0.323
68

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-96-5p 22 CCND2 Sponge network -0.582 0.05253 -1.641 0 0.322
69

LINC00092

 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-503-5p;hsa-miR-589-3p;hsa-miR-590-3p 14 CCND2 Sponge network -2.383 0 -1.641 0 0.321
70

LINC00922

 hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-330-5p;hsa-miR-421;hsa-miR-589-5p;hsa-miR-628-5p;hsa-miR-7-1-3p 11 PRICKLE2 Sponge network -0.842 0.11239 -1.561 0 0.32
71

SNHG18

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-212-3p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-629-3p 11 PRICKLE2 Sponge network -1.073 0.00533 -1.561 0 0.319
72

AC007743.1

 hsa-miR-148b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-33a-5p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 12 PRICKLE2 Sponge network -2.595 0 -1.561 0 0.319
73

TBX5-AS1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 14 FZD4 Sponge network -2.108 0 -1.785 0 0.318
74

RP11-456K23.1

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-301a-3p;hsa-miR-424-5p;hsa-miR-542-3p;hsa-miR-590-3p;hsa-miR-590-5p 14 FZD4 Sponge network -1.488 0 -1.785 0 0.317
75

RP5-1042I8.7

 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-20a-5p;hsa-miR-320b;hsa-miR-331-5p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-96-5p 13 CCND2 Sponge network -0.733 0.00018 -1.641 0 0.316
76

AC079630.4

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-331-5p;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p 19 CCND2 Sponge network -3.758 0 -1.641 0 0.314
77

LINC00702

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 14 FZD4 Sponge network -2.856 0 -1.785 0 0.314
78

AC079630.4

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-421;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 12 PRICKLE2 Sponge network -3.758 0 -1.561 0 0.312
79

AF131215.9

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-450b-5p;hsa-miR-590-3p;hsa-miR-628-5p 11 PRICKLE2 Sponge network -1.808 0 -1.561 0 0.312
80

LINC00607

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-330-5p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 11 PRICKLE2 Sponge network -2.277 0 -1.561 0 0.312
81 DIO3OS hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-550a-5p;hsa-miR-877-5p 14 CCND2 Sponge network -1.936 0.00085 -1.641 0 0.307
82

LINC00472

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-301a-3p;hsa-miR-424-5p;hsa-miR-7-1-3p 10 FZD4 Sponge network -2.952 0 -1.785 0 0.305
83 RP11-283G6.4 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-450b-5p;hsa-miR-93-5p;hsa-miR-96-5p 12 CCND2 Sponge network -3.669 1.0E-5 -1.641 0 0.305
84

RP11-401P9.4

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-542-3p;hsa-miR-590-5p;hsa-miR-708-5p 13 FZD4 Sponge network -3.04 0 -1.785 0 0.304
85 CTC-366B18.4 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-93-5p 10 CCND2 Sponge network -0.652 0.01265 -1.641 0 0.303
86

FENDRR

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-331-5p;hsa-miR-450b-5p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 22 CCND2 Sponge network -4.222 0 -1.641 0 0.301
87

RP11-378A13.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-877-5p;hsa-miR-93-5p 20 CCND2 Sponge network -1.713 0 -1.641 0 0.301
88 BAIAP2-AS1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-365a-3p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-942-5p 12 CCND1 Sponge network -0.182 0.51705 -0.296 0.2554 0.3
89 RP4-647J21.1 hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-550a-5p;hsa-miR-93-5p 10 CCND2 Sponge network -0.153 0.73575 -1.641 0 0.299
90

AC011899.9

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 12 PRICKLE2 Sponge network -2.611 0 -1.561 0 0.298
91

LINC00922

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-324-3p;hsa-miR-501-5p;hsa-miR-7-1-3p;hsa-miR-877-5p 14 CCND2 Sponge network -0.842 0.11239 -1.641 0 0.298
92

RP11-476D10.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-96-5p 19 CCND2 Sponge network -4.519 0 -1.641 0 0.296
93

LINC00702

 hsa-miR-106b-5p;hsa-miR-142-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-21-5p;hsa-miR-210-3p;hsa-miR-450b-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 10 APC Sponge network -2.856 0 -0.814 0 0.295
94 RP11-416I2.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-769-3p;hsa-miR-92a-3p;hsa-miR-93-5p;hsa-miR-942-5p 13 CCND1 Sponge network 3.177 1.0E-5 -0.296 0.2554 0.294
95

CYP1B1-AS1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-212-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 13 PRICKLE2 Sponge network -1.073 0.00045 -1.561 0 0.293
96

RP11-456K23.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-450b-5p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 23 CCND2 Sponge network -1.488 0 -1.641 0 0.292
97

LINC00961

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-589-3p;hsa-miR-96-5p 16 CCND2 Sponge network -2.724 0 -1.641 0 0.292
98 RP11-400K9.4 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-93-5p 12 CCND2 Sponge network -1.193 0.00359 -1.641 0 0.29
99

AC004947.2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-450b-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p 17 CCND2 Sponge network -3.94 0 -1.641 0 0.289
100

CASC2

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 14 PRICKLE2 Sponge network -1.086 0 -1.561 0 0.288
101

RP11-166D19.1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-421;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-628-5p;hsa-miR-7-1-3p 18 PRICKLE2 Sponge network -0.582 0.05253 -1.561 0 0.288
102 AC006129.1 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-877-5p 11 CCND2 Sponge network -1.587 0.00086 -1.641 0 0.287
103

SH3RF3-AS1

 hsa-miR-15a-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-3p;hsa-miR-503-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 12 CCND2 Sponge network -1.583 0 -1.641 0 0.286
104

RP11-1008C21.2

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-330-5p;hsa-miR-629-3p 11 PRICKLE2 Sponge network -1.249 0 -1.561 0 0.283
105

RP11-1008C21.1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-590-3p;hsa-miR-628-5p;hsa-miR-629-3p 13 PRICKLE2 Sponge network -1.826 3.0E-5 -1.561 0 0.282
106

NR2F1-AS1

 hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 14 PRICKLE2 Sponge network -0.427 0.1559 -1.561 0 0.28
107

RP11-532F6.3

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-33a-5p;hsa-miR-576-5p;hsa-miR-629-3p 11 PRICKLE2 Sponge network -2.028 0 -1.561 0 0.274
108 AC010226.4 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-93-5p 10 CCND2 Sponge network -1.081 2.0E-5 -1.641 0 0.272
109

MIR497HG

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-503-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p;hsa-miR-96-5p 27 CCND2 Sponge network -2.142 0 -1.641 0 0.271
110

DNM3OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-191-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-501-5p;hsa-miR-550a-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 16 CCND2 Sponge network 0.053 0.85755 -1.641 0 0.27
111

C1orf132

 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-151a-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-21-3p;hsa-miR-2355-3p;hsa-miR-28-5p;hsa-miR-320b;hsa-miR-450b-5p;hsa-miR-503-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-877-5p;hsa-miR-93-5p 15 CCND2 Sponge network -0.86 0.02429 -1.641 0 0.269
112

LINC00968

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-301a-3p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-708-5p 14 FZD4 Sponge network -4.19 0 -1.785 0 0.268
113 RP11-20J15.3 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-550a-5p;hsa-miR-877-5p 11 CCND2 Sponge network -1.709 0.0268 -1.641 0 0.264
114 AC022182.3 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-877-5p;hsa-miR-93-5p 10 CCND2 Sponge network -0.559 0.20451 -1.641 0 0.263
115

RP11-536K7.3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-877-5p;hsa-miR-93-5p 13 CCND2 Sponge network -1.239 5.0E-5 -1.641 0 0.263
116

MAGI2-AS3

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-942-5p 12 FBXW11 Sponge network -1.892 0 -0.304 0.01022 0.26
117

RP5-839B4.8

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-629-3p;hsa-miR-7-1-3p 12 PRICKLE2 Sponge network -5.037 0 -1.561 0 0.258
118

AC003991.3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-365a-3p;hsa-miR-425-5p;hsa-miR-769-3p;hsa-miR-92a-3p;hsa-miR-93-5p 14 CCND1 Sponge network -0.787 0.08132 -0.296 0.2554 0.255
119

RP11-476D10.1

 hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-33a-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 10 PRICKLE2 Sponge network -4.519 0 -1.561 0 0.253
120 RP11-53M11.3 hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-301a-3p;hsa-miR-7-1-3p 10 CCND2 Sponge network -2.058 0.01204 -1.641 0 0.253
121

AC004947.2

 hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-335-3p;hsa-miR-421;hsa-miR-450b-5p;hsa-miR-576-5p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-7-1-3p 15 PRICKLE2 Sponge network -3.94 0 -1.561 0 0.253
122

MAGI2-AS3

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-7-1-3p 14 FZD4 Sponge network -1.892 0 -1.785 0 0.252

Quest ID: 85497b77fc20d2cd954c9365bddd61a9